株探米国株
英語
エドガーで原本を確認する
http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent0000046129--12-312023Q3false00http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNethttp://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet1628000015978000http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrentP30Dhttp://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#LongTermDebtNoncurrenthttp://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#LongTermDebtNoncurrentfalsefalsefalsefalse0000046129us-gaap:RetainedEarningsMember2023-09-300000046129us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-09-300000046129us-gaap:AccumulatedTranslationAdjustmentMember2023-09-300000046129us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300000046129us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-09-300000046129us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-09-300000046129amot:AccumulatedTaxEffectOfCashFlowHedgesParentMember2023-09-300000046129amot:AccumulatedGainLossNetBeforeTaxCashFlowHedgeParentMember2023-09-300000046129us-gaap:RetainedEarningsMember2023-06-300000046129us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-06-300000046129us-gaap:AccumulatedTranslationAdjustmentMember2023-06-300000046129us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300000046129us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-06-300000046129us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-06-300000046129amot:AccumulatedTaxEffectOfCashFlowHedgesParentMember2023-06-300000046129amot:AccumulatedGainLossNetBeforeTaxCashFlowHedgeParentMember2023-06-3000000461292023-06-300000046129us-gaap:RetainedEarningsMember2023-03-310000046129us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-03-310000046129us-gaap:AccumulatedTranslationAdjustmentMember2023-03-310000046129us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-03-310000046129us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-03-3100000461292023-03-310000046129us-gaap:RetainedEarningsMember2022-12-310000046129us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-12-310000046129us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310000046129us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000046129us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310000046129us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310000046129amot:AccumulatedTaxEffectOfCashFlowHedgesParentMember2022-12-310000046129amot:AccumulatedGainLossNetBeforeTaxCashFlowHedgeParentMember2022-12-310000046129us-gaap:RetainedEarningsMember2022-09-300000046129us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-09-300000046129us-gaap:AccumulatedTranslationAdjustmentMember2022-09-300000046129us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-300000046129us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-09-300000046129us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-09-300000046129amot:AccumulatedTaxEffectOfCashFlowHedgesParentMember2022-09-300000046129amot:AccumulatedGainLossNetBeforeTaxCashFlowHedgeParentMember2022-09-300000046129us-gaap:RetainedEarningsMember2022-06-300000046129us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-06-300000046129us-gaap:AccumulatedTranslationAdjustmentMember2022-06-300000046129us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300000046129us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-06-300000046129us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-06-300000046129amot:AccumulatedTaxEffectOfCashFlowHedgesParentMember2022-06-300000046129amot:AccumulatedGainLossNetBeforeTaxCashFlowHedgeParentMember2022-06-3000000461292022-06-300000046129us-gaap:RetainedEarningsMember2022-03-310000046129us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-03-310000046129us-gaap:AccumulatedTranslationAdjustmentMember2022-03-310000046129us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-03-310000046129us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-03-3100000461292022-03-310000046129us-gaap:RetainedEarningsMember2021-12-310000046129us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2021-12-310000046129us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310000046129us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000046129us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-12-310000046129us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-310000046129amot:AccumulatedTaxEffectOfCashFlowHedgesParentMember2021-12-310000046129amot:AccumulatedGainLossNetBeforeTaxCashFlowHedgeParentMember2021-12-310000046129us-gaap:RestrictedStockMember2023-09-300000046129us-gaap:RestrictedStockMember2022-12-310000046129amot:VestingBasedOnPerformanceMemberus-gaap:RestrictedStockMember2023-01-012023-09-300000046129us-gaap:RestrictedStockMember2023-07-012023-09-300000046129us-gaap:RestrictedStockMember2022-07-012022-09-300000046129us-gaap:RestrictedStockMember2022-01-012022-09-300000046129srt:EuropeMember2023-07-012023-09-300000046129srt:AsiaMember2023-07-012023-09-300000046129country:US2023-07-012023-09-300000046129amot:VehicleMember2023-07-012023-09-300000046129amot:MedicalMember2023-07-012023-09-300000046129amot:IndustrialAndElectronicsMember2023-07-012023-09-300000046129amot:DistributionAndOtherTargetMarketMember2023-07-012023-09-300000046129amot:AerospaceAndDefenseMember2023-07-012023-09-300000046129srt:EuropeMember2023-01-012023-09-300000046129srt:AsiaMember2023-01-012023-09-300000046129country:US2023-01-012023-09-300000046129amot:VehicleMember2023-01-012023-09-300000046129amot:MedicalMember2023-01-012023-09-300000046129amot:IndustrialAndElectronicsMember2023-01-012023-09-300000046129amot:DistributionAndOtherTargetMarketMember2023-01-012023-09-300000046129amot:AerospaceAndDefenseMember2023-01-012023-09-300000046129srt:EuropeMember2022-07-012022-09-300000046129srt:AsiaMember2022-07-012022-09-300000046129country:US2022-07-012022-09-300000046129amot:VehicleMember2022-07-012022-09-300000046129amot:MedicalMember2022-07-012022-09-300000046129amot:IndustrialAndElectronicsMember2022-07-012022-09-300000046129amot:DistributionAndOtherTargetMarketMember2022-07-012022-09-300000046129amot:AerospaceAndDefenseMember2022-07-012022-09-300000046129srt:EuropeMember2022-01-012022-09-300000046129srt:AsiaMember2022-01-012022-09-300000046129country:US2022-01-012022-09-300000046129amot:VehicleMember2022-01-012022-09-300000046129amot:MedicalMember2022-01-012022-09-300000046129amot:IndustrialAndElectronicsMember2022-01-012022-09-300000046129amot:DistributionAndOtherTargetMarketMember2022-01-012022-09-300000046129amot:AerospaceAndDefenseMember2022-01-012022-09-300000046129us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestExpenseMember2023-07-012023-09-300000046129us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestExpenseMember2023-01-012023-09-300000046129us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestExpenseMember2022-07-012022-09-300000046129us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestExpenseMember2022-01-012022-09-3000000461292022-01-012022-12-310000046129us-gaap:MachineryAndEquipmentMember2023-09-300000046129us-gaap:LandMember2023-09-300000046129us-gaap:ConstructionInProgressMember2023-09-300000046129us-gaap:BuildingAndBuildingImprovementsMember2023-09-300000046129amot:FurnitureFixturesAndOtherMember2023-09-300000046129us-gaap:MachineryAndEquipmentMember2022-12-310000046129us-gaap:LandMember2022-12-310000046129us-gaap:ConstructionInProgressMember2022-12-310000046129us-gaap:BuildingAndBuildingImprovementsMember2022-12-310000046129amot:FurnitureFixturesAndOtherMember2022-12-310000046129us-gaap:AccumulatedTranslationAdjustmentMember2023-04-012023-06-300000046129us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-03-310000046129us-gaap:AccumulatedTranslationAdjustmentMember2022-04-012022-06-300000046129us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-03-310000046129us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-07-012023-09-300000046129us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-04-012023-06-300000046129us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-03-310000046129us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-07-012022-09-300000046129us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-04-012022-06-300000046129us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-012022-03-310000046129us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2023-07-012023-09-300000046129amot:AccumulatedGainLossNetBeforeTaxCashFlowHedgeParentMember2023-07-012023-09-300000046129us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2023-01-012023-09-300000046129amot:AccumulatedGainLossNetBeforeTaxCashFlowHedgeParentMember2023-01-012023-09-300000046129us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2022-07-012022-09-300000046129amot:AccumulatedGainLossNetBeforeTaxCashFlowHedgeParentMember2022-07-012022-09-300000046129us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2022-01-012022-09-300000046129amot:AccumulatedGainLossNetBeforeTaxCashFlowHedgeParentMember2022-01-012022-09-300000046129amot:AccumulatedTaxEffectOfCashFlowHedgesParentMember2023-07-012023-09-300000046129amot:AccumulatedTaxEffectOfCashFlowHedgesParentMember2023-01-012023-09-300000046129amot:AccumulatedTaxEffectOfCashFlowHedgesParentMember2022-07-012022-09-300000046129amot:AccumulatedTaxEffectOfCashFlowHedgesParentMember2022-01-012022-09-300000046129us-gaap:AccumulatedTranslationAdjustmentMember2023-07-012023-09-300000046129us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300000046129us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-09-300000046129us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300000046129us-gaap:AccumulatedTranslationAdjustmentMember2022-07-012022-09-300000046129us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-300000046129us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-09-300000046129us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-09-300000046129srt:ExecutiveOfficerMember2023-07-012023-09-300000046129srt:ExecutiveOfficerMember2023-01-012023-09-300000046129srt:MinimumMemberamot:AmendedRevolvingCreditFacilityMember2023-01-012023-09-300000046129srt:MaximumMemberamot:AmendedRevolvingCreditFacilityMember2023-01-012023-09-300000046129srt:ExecutiveOfficerMember2023-09-300000046129us-gaap:AccruedLiabilitiesMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-09-300000046129us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-09-300000046129us-gaap:OtherAssetsMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-09-300000046129us-gaap:DesignatedAsHedgingInstrumentMember2023-09-300000046129us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310000046129us-gaap:OtherAssetsMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310000046129us-gaap:DesignatedAsHedgingInstrumentMember2022-12-310000046129us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestExpenseMember2023-07-012023-09-300000046129us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestExpenseMember2023-01-012023-09-300000046129us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestExpenseMember2022-07-012022-09-300000046129us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestExpenseMember2022-01-012022-09-300000046129us-gaap:NonoperatingIncomeExpenseMember2023-07-012023-09-300000046129us-gaap:NonoperatingIncomeExpenseMember2023-01-012023-09-300000046129us-gaap:NonoperatingIncomeExpenseMember2022-07-012022-09-300000046129us-gaap:NonoperatingIncomeExpenseMember2022-01-012022-09-300000046129us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-09-300000046129us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310000046129srt:MinimumMemberus-gaap:TradeNamesMember2023-09-300000046129srt:MinimumMemberus-gaap:CustomerListsMember2023-09-300000046129srt:MinimumMemberamot:DesignAndTechnologiesMember2023-09-300000046129srt:MaximumMemberus-gaap:TradeNamesMember2023-09-300000046129srt:MaximumMemberus-gaap:CustomerListsMember2023-09-300000046129srt:MaximumMemberamot:DesignAndTechnologiesMember2023-09-300000046129us-gaap:TradeNamesMember2023-09-300000046129us-gaap:CustomerListsMember2023-09-300000046129amot:DesignAndTechnologiesMember2023-09-300000046129us-gaap:TradeNamesMember2022-12-310000046129us-gaap:CustomerListsMember2022-12-310000046129amot:DesignAndTechnologiesMember2022-12-310000046129us-gaap:RetainedEarningsMember2023-07-012023-09-300000046129us-gaap:RetainedEarningsMember2023-04-012023-06-300000046129us-gaap:RetainedEarningsMember2023-01-012023-03-310000046129us-gaap:RetainedEarningsMember2022-07-012022-09-300000046129us-gaap:RetainedEarningsMember2022-04-012022-06-300000046129us-gaap:RetainedEarningsMember2022-01-012022-03-310000046129us-gaap:ForeignExchangeContractMember2023-09-300000046129us-gaap:ForeignExchangeContractMember2022-12-310000046129us-gaap:InterestRateSwapMember2023-01-012023-09-300000046129us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-09-300000046129us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310000046129amot:AmendedRevolvingCreditFacilityMember2023-09-300000046129srt:MinimumMemberamot:AmendedRevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-01-012023-09-300000046129srt:MaximumMemberamot:AmendedRevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-01-012023-09-300000046129amot:AmendedRevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-01-012023-09-300000046129amot:AmendedRevolvingCreditFacilityMemberus-gaap:BaseRateMember2023-01-012023-09-300000046129country:USus-gaap:SalesRevenueNetMemberus-gaap:GeographicConcentrationRiskMember2023-07-012023-09-300000046129country:USus-gaap:SalesRevenueNetMemberus-gaap:GeographicConcentrationRiskMember2023-01-012023-09-300000046129amot:CustomerMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-09-300000046129amot:CustomerMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-09-300000046129amot:CustomerBMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-09-300000046129country:USus-gaap:SalesRevenueNetMemberus-gaap:GeographicConcentrationRiskMember2022-07-012022-09-300000046129amot:CustomerBMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2022-07-012022-09-300000046129country:USus-gaap:SalesRevenueNetMemberus-gaap:GeographicConcentrationRiskMember2022-01-012022-09-300000046129amot:CustomerBMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-09-300000046129us-gaap:CommonStockMember2023-09-300000046129us-gaap:CommonStockMember2023-06-300000046129us-gaap:CommonStockMember2023-03-310000046129us-gaap:CommonStockMember2022-12-310000046129us-gaap:CommonStockMember2022-09-300000046129us-gaap:CommonStockMember2022-06-300000046129us-gaap:CommonStockMember2022-03-310000046129us-gaap:CommonStockMember2021-12-3100000461292022-09-3000000461292021-12-310000046129amot:FPHGroupIncMember2023-04-012023-06-300000046129amot:SierramotionIncMember2023-09-222023-09-220000046129amot:ThinGapIncAndAirexLLCMember2023-01-012023-09-300000046129amot:FPHGroupIncMember2022-05-302022-05-300000046129amot:SierramotionIncMember2023-09-220000046129amot:AirexLLCMember2022-06-170000046129amot:ThinGapIncMember2022-05-240000046129amot:OutsideUnitedStatesMember2023-09-300000046129amot:OutsideUnitedStatesMember2022-12-3100000461292023-11-010000046129us-gaap:CommonStockMember2023-07-012023-09-300000046129us-gaap:CommonStockMember2023-04-012023-06-300000046129us-gaap:CommonStockMember2023-01-012023-03-310000046129us-gaap:CommonStockMember2022-07-012022-09-300000046129us-gaap:CommonStockMember2022-04-012022-06-300000046129us-gaap:CommonStockMember2022-01-012022-03-310000046129us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-07-012023-09-300000046129us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-04-012023-06-3000000461292023-04-012023-06-300000046129us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-01-012023-03-3100000461292023-01-012023-03-310000046129us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-07-012022-09-300000046129us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-04-012022-06-3000000461292022-04-012022-06-300000046129us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-01-012022-03-3100000461292022-01-012022-03-310000046129us-gaap:RestrictedStockMember2023-01-012023-09-300000046129us-gaap:RevolvingCreditFacilityMember2023-09-300000046129us-gaap:RevolvingCreditFacilityMember2022-12-310000046129amot:ForQuarterEndingOnOrAfterDecember312023Memberamot:AmendedRevolvingCreditFacilityMember2023-01-012023-09-300000046129amot:AmendedRevolvingCreditFacilityMember2023-01-012023-09-300000046129us-gaap:InterestRateSwapMember2022-03-310000046129us-gaap:InterestRateSwapMember2020-03-310000046129us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-09-300000046129us-gaap:OtherNoncurrentLiabilitiesMember2023-09-300000046129us-gaap:AccruedLiabilitiesMember2023-09-300000046129us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310000046129us-gaap:OtherNoncurrentLiabilitiesMember2022-12-310000046129amot:CustomerMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2023-07-012023-09-300000046129amot:CustomerBMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2023-07-012023-09-300000046129us-gaap:AccruedLiabilitiesMemberamot:SpectrumControlsInc.Member2023-01-012023-09-300000046129us-gaap:OtherNoncurrentLiabilitiesMemberamot:SpectrumControlsInc.Member2022-01-012022-12-310000046129us-gaap:AccruedLiabilitiesMemberamot:SpectrumControlsInc.Member2022-01-012022-12-310000046129amot:FPHGroupIncMember2022-05-300000046129amot:SpectrumControlsInc.Member2024-01-032024-01-030000046129amot:SpectrumControlsInc.Member2021-12-302021-12-3000000461292023-07-012023-09-300000046129amot:AlioIndustriesMember2023-09-3000000461292022-07-012022-09-3000000461292022-01-012022-09-3000000461292023-01-012023-09-3000000461292023-09-3000000461292022-12-31iso4217:USDxbrli:pureamot:paymentamot:customerxbrli:sharesiso4217:USDxbrli:sharesamot:derivativeamot:segment

Table of Contents

927

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

Form 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2023.

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________________________to _________________________

Commission file number 0-04041

ALLIENT INC.

(Exact name of Registrant as Specified in Its Charter)

Colorado

    

84-0518115

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

495 Commerce Drive, Amherst, New York
(Address of principal executive offices)

14228
(Zip Code)

(716) 242-8634

(Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

    

Trading Symbol

    

Name of each exchange on which registered

Common stock

ALNT

NASDAQ

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past ninety (90) days. Yes  ⌧  No  ◻

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).  Yes  ⌧  No  ◻

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Securities Exchange Act.

Large accelerated filer ◻

Accelerated filer ⌧

Non-accelerated filer ◻

Smaller reporting company ☐

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ◻

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  ☐  No  ⌧

Number of Shares of the only class of Common Stock outstanding: 16,211,259 as of November 1, 2023

Table of Contents

ALLIENT INC.

INDEX

PART I. FINANCIAL INFORMATION

Page No.

Item 1.

Financial Statements

 

Condensed Consolidated Balance Sheets – Unaudited

1

Condensed Consolidated Statements of Income and Comprehensive Income (Loss) – Unaudited

2

Condensed Consolidated Statements of Stockholders’ Equity – Unaudited

3

Condensed Consolidated Statements of Cash Flows – Unaudited

4

Notes to Condensed Consolidated Financial Statements – Unaudited

5

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

19

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

27

Item 4.

Controls and Procedures

28

PART II. OTHER INFORMATION

29

Item 1A.

Risk Factors

29

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

29

Item 5.

Other Information

29

Item 6.

Exhibits

29

Table of Contents

ALLIENT INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except per share data)

(Unaudited)

September 30, 

December 31, 

    

2023

    

2022

    

Assets

Current assets:

Cash and cash equivalents

$

23,836

$

30,614

Trade receivables, net of provision for credit losses of $1,220 and $1,192 at September 30, 2023 and December 31, 2022, respectively

90,631

76,213

Inventories

 

117,291

 

117,108

Prepaid expenses and other assets

 

13,045

 

12,072

Total current assets

 

244,803

 

236,007

Property, plant, and equipment, net

 

67,895

 

68,640

Deferred income taxes

 

3,447

 

4,199

Intangible assets, net

 

113,791

 

119,075

Goodwill

 

130,298

 

126,366

Operating lease assets

24,977

22,807

Other long-term assets

 

11,380

 

11,253

Total Assets

$

596,591

$

588,347

Liabilities and Stockholders’ Equity

Current liabilities:

Accounts payable

$

42,470

$

39,467

Accrued liabilities

 

52,237

 

48,121

Total current liabilities

 

94,707

 

87,588

Long-term debt

 

224,364

 

235,454

Deferred income taxes

 

5,804

 

6,262

Pension and post-retirement obligations

 

2,893

 

3,009

Operating lease liabilities

20,291

18,795

Other long-term liabilities

6,391

21,774

Total liabilities

 

354,450

 

372,882

Stockholders’ Equity:

Common stock, no par value, authorized 50,000 shares; 16,280 and 15,978 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively

 

94,742

 

83,852

Preferred stock, par value $1.00 per share, authorized 5,000 shares; no shares issued or outstanding

 

 

Retained earnings

 

161,953

 

143,576

Accumulated other comprehensive loss

 

(14,554)

 

(11,963)

Total stockholders’ equity

 

242,141

 

215,465

Total Liabilities and Stockholders’ Equity

$

596,591

$

588,347

See accompanying notes to condensed consolidated financial statements.

1

Table of Contents

ALLIENT INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (LOSS)

(In thousands, except per share data)

(Unaudited)

For the three months ended

For the nine months ended

September 30, 

September 30, 

    

2023

    

2022

    

2023

    

2022

    

Revenues

$

145,319

$

134,405

$

437,637

$

371,912

Cost of goods sold

 

97,821

 

91,108

 

298,328

 

255,381

Gross profit

 

47,498

 

43,297

 

139,309

 

116,531

Operating costs and expenses:

Selling

 

6,021

 

5,497

 

18,354

 

16,336

General and administrative

 

14,642

 

13,148

 

43,624

 

37,239

Engineering and development

 

10,702

 

9,702

 

31,041

 

28,879

Business development

 

1,194

 

199

 

1,791

 

2,464

Amortization of intangible assets

 

3,075

 

3,054

 

9,226

 

8,133

Total operating costs and expenses

 

35,634

 

31,600

 

104,036

 

93,051

Operating income

 

11,864

 

11,697

 

35,273

 

23,480

Other expense, net:

Interest expense

 

3,164

 

2,337

 

9,309

 

4,900

Other expense, net

 

42

 

243

 

187

 

9

Total other expense, net

 

3,206

 

2,580

 

9,496

 

4,909

Income before income taxes

 

8,658

 

9,117

 

25,777

 

18,571

Income tax provision

 

(1,992)

 

(2,508)

 

(6,027)

 

(4,878)

Net income

$

6,666

$

6,609

$

19,750

$

13,693

Basic earnings per share:

Earnings per share

$

0.42

$

0.42

$

1.24

$

0.89

Basic weighted average common shares

 

15,979

 

15,661

 

15,940

 

15,373

Diluted earnings per share:

Earnings per share

$

0.41

$

0.41

$

1.22

$

0.86

Diluted weighted average common shares

 

16,237

 

16,169

 

16,198

 

15,929

Net income

$

6,666

$

6,609

$

19,750

$

13,693

Other comprehensive income (loss):

Foreign currency translation adjustment

(2,923)

(9,603)

(1,995)

(19,535)

(Loss) gain on derivatives, net of tax

(170)

2,042

(596)

5,617

Comprehensive income (loss)

$

3,573

$

(952)

$

17,159

$

(225)

See accompanying notes to condensed consolidated financial statements.

2

Table of Contents

ALLIENT INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(In thousands, except per share data)

(Unaudited)

Common Stock

  

Accumulated Other Comprehensive (Loss) Income

(In thousands except per share data)

Shares

    

Amount

    

Retained Earnings

    

Foreign Currency Translation Adjustments

    

Accumulated income (loss) on derivatives

    

Pension adjustments

    

Total Stockholders' Equity

Balances, December 31, 2022

15,978

$

83,852

$

143,576

$

(16,925)

$

5,556

$

(594)

$

215,465

Stock transactions under employee benefit stock plans

31

1,246

 

1,246

Issuance of restricted stock, net of forfeitures

103

(34)

 

(34)

Share issuance in connection with acquisition

185

6,250

6,250

Stock-based compensation expense

1,267

 

1,267

Shares withheld for payment of employee payroll taxes

(4)

(146)

(146)

Comprehensive income (loss)

1,354

(1,565)

(211)

Tax effect of derivative transactions

432

432

Net income

 

 

6,315

 

6,315

Dividends to stockholders - $0.025

(403)

(403)

Balances, March 31, 2023

16,293

$

92,435

$

149,488

$

(15,571)

$

4,423

$

(594)

$

230,181

Issuance of restricted stock, net of forfeitures

14

11

 

11

Stock-based compensation expense

1,544

 

1,544

Shares withheld for payment of employee payroll taxes

(39)

(1,507)

(1,507)

Comprehensive (loss) income

(426)

930

504

Tax effect of derivative transactions

(223)

(223)

Net income

6,769

6,769

Dividends to stockholders - $0.03

(485)

 

(485)

Balances, June 30, 2023

16,268

$

92,483

$

155,772

$

(15,997)

$

5,130

$

(594)

$

236,794

Issuance of restricted stock, net of forfeitures

(18)

 

Share issuance in connection with acquisitions

35

1,079

1,079

Stock-based compensation expense

1,354

 

1,354

Shares withheld for payment of employee payroll taxes

(5)

(174)

(174)

Comprehensive (loss) income

(2,923)

(224)

(3,147)

Tax effect of derivative transactions

54

54

Net income

6,666

6,666

Dividends to stockholders - $0.03

 

 

(485)

 

(485)

Balances, September 30, 2023

16,280

$

94,742

$

161,953

$

(18,920)

$

4,960

$

(594)

$

242,141

Common Stock

  

Accumulated Other Comprehensive (Loss) Income

(In thousands except per share data)

Shares

    

Amount

    

Retained Earnings

    

Foreign Currency Translation Adjustments

    

Accumulated income (loss) on derivatives

    

Pension adjustments

    

Total Stockholders' Equity

Balances, December 31, 2021

15,361

$

68,097

$

127,757

$

(7,409)

$

180

$

(863)

$

187,762

Stock transactions under employee benefit stock plans

36

1,217

 

1,217

Issuance of restricted stock, net of forfeitures

141

(4)

 

(4)

Stock-based compensation expense

1,349

 

1,349

Shares withheld for payment of employee payroll taxes

(4)

(137)

(137)

Comprehensive (loss) income

(1,233)

3,423

2,190

Tax effect of derivative transactions

(822)

(822)

Net income

 

 

2,504

 

2,504

Dividends to stockholders - $0.025

(388)

(388)

Balances, March 31, 2022

15,534

$

70,522

$

129,873

$

(8,642)

$

2,781

$

(863)

$

193,671

Issuance of restricted stock, net of forfeitures

16

(1)

 

(1)

Share issuance in connection with acquisitions

463

11,103

11,103

Stock-based compensation expense

1,141

 

1,141

Shares withheld for payment of employee payroll taxes

(35)

(1,103)

(1,103)

Comprehensive (loss) income

(8,699)

1,284

(7,415)

Tax effect of derivative transactions

(310)

(310)

Net income

4,581

4,581

Dividends to stockholders - $0.025

 

 

(388)

 

(388)

Balances, June 30, 2022

15,978

$

81,662

$

134,066

$

(17,341)

$

3,755

$

(863)

$

201,279

Issuance of restricted stock, net of forfeitures

7

 

Stock-based compensation expense

1,262

 

1,262

Shares withheld for payment of employee payroll taxes

(3)

(94)

(94)

Comprehensive (loss) income

(9,603)

2,687

(6,916)

Tax effect of derivative transactions

(645)

(645)

Net income

6,609

6,609

Dividends to stockholders - $0.025

 

 

(398)

 

(398)

Balances, September 30, 2022

15,982

$

82,830

$

140,277

$

(26,944)

$

5,797

$

(863)

$

201,097

See accompanying notes to condensed consolidated financial statements.

3

Table of Contents

ALLIENT INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

For the nine months ended

September 30, 

    

2023

    

2022

    

Cash Flows From Operating Activities:

Net income

$

19,750

$

13,693

Adjustments to reconcile net income to net cash provided by (used in) operating activities

Depreciation and amortization

 

18,956

 

19,222

Deferred income taxes

 

122

 

2,775

Stock-based compensation expense

4,165

3,752

Debt issue cost amortization recorded in interest expense

225

127

Other

 

987

 

785

Changes in operating assets and liabilities, net of acquisitions:

Trade receivables

 

(14,358)

 

(27,560)

Inventories

 

(1,344)

 

(25,782)

Prepaid expenses and other assets

 

(1,553)

 

(3,133)

Accounts payable

 

2,871

 

6,501

Accrued liabilities

 

(2,689)

 

3,796

Net cash provided by (used in) operating activities

 

27,132

 

(5,824)

Cash Flows From Investing Activities:

Consideration paid for acquisitions, net of cash acquired

 

(11,004)

 

(44,596)

Purchase of property and equipment

(7,850)

(11,026)

Net cash used in investing activities

 

(18,854)

 

(55,622)

Cash Flows From Financing Activities:

Proceeds from issuance of long-term debt

 

11,000

 

69,952

Principal payments of long-term debt and finance lease obligations

(22,325)

(6,514)

Dividends paid to stockholders

 

(1,348)

 

(1,147)

Tax withholdings related to net share settlements of restricted stock

(1,827)

(1,334)

Net cash (used in) provided by financing activities

 

(14,500)

 

60,957

Effect of foreign exchange rate changes on cash

 

(556)

 

(2,269)

Net decrease in cash and cash equivalents

 

(6,778)

 

(2,758)

Cash and cash equivalents at beginning of period

 

30,614

 

22,463

Cash and cash equivalents at end of period

$

23,836

$

19,705

Supplemental disclosure of cash flow information:

Stock issued for acquisitions

$

7,329

$

11,103

Property, plant and equipment purchases in accounts payable or accrued expenses

$

1,960

$

719

Accrued consideration for acquisition

$

185

$

See accompanying notes to condensed consolidated financial statements.

4

Table of Contents

ALLIENT INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

1.    BASIS OF PREPARATION AND PRESENTATION

Effective August 23, 2023, Allied Motion Technologies Inc. (“Allied Motion”) changed its name to Allient Inc. (“Allient” or the “Company”). In conjunction with the name change, Allient’s ticker symbol has changed from “AMOT” to “ALNT”. The name change reflects the Company’s evolution of its business to transform from a products-based business in motion control to a solutions-oriented company that addresses its customers’ requirements for Motion, Controls and Power technologies for a multitude of applications.

Allient is engaged in the business of designing, manufacturing, and selling precision motion, control, power and structural composites to provide integrated system solutions as well as individual products, to a broad spectrum of customers throughout the world primarily for the industrial, vehicle, medical, and aerospace and defense markets.

The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.

The assets and liabilities of the Company’s foreign subsidiaries are translated into U.S. dollars using end of period exchange rates. Changes in reported amounts of assets and liabilities of foreign subsidiaries that occur as a result of changes in exchange rates between the foreign subsidiaries’ functional currencies and the U.S. dollar are included in foreign currency translation adjustment. Foreign currency translation adjustment is included in accumulated other comprehensive loss, a component of stockholders’ equity in the accompanying condensed consolidated statements of stockholders’ equity. Revenue and expense transactions use an average rate prevailing during the month of the related transaction. Transaction gains and losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency of each of the foreign subsidiaries are included in the results of operations as incurred in other expense, net.

The condensed consolidated financial statements included herein have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and include all adjustments which are, in the opinion of management, necessary for a fair presentation. Certain information and footnote disclosures normally included in financial statements which are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to such rules and regulations. The Company believes that the disclosures herein are adequate to make the information presented not misleading. The financial data for the interim periods may not necessarily be indicative of results to be expected for the year.

The preparation of financial statements in accordance with U.S. GAAP requires management to make certain estimates and assumptions. Such estimates and assumptions affect the reported amounts of assets and liabilities as well as disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.

It is suggested that the accompanying condensed consolidated financial statements be read in conjunction with the Consolidated Financial Statements and related Notes to such statements included in the Annual Report on Form 10-K for the year ended December 31, 2022 that was previously filed by the Company.

5

Table of Contents

ALLIENT INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

2.

ACQUISITIONS

On September 22, 2023, the Company acquired 100% of the ownership interest in Sierramotion Inc. (“Sierramotion”), a company headquartered in California, that specializes in designing and engineering turn-key motion components and mechatronic solutions for robotic, medical, industrial, defense, semiconductor, and other precision applications. The preliminary purchase price for Sierramotion of $8.4 million includes contingent consideration payable (Note 12) and at closing consisted of a combination of cash and Company stock. The intangible assets and goodwill are expected to be deductible for tax purposes. The preliminary purchase price allocation is subject to adjustments based on a determination of closing net working capital and certain tax matters. Transaction costs for the acquisition were not material. The operating results of this acquisition are included in the condensed consolidated financial statements beginning on the acquisition date and the revenue and earnings in the current year interim periods presented are not material.

On May 30, 2022, the Company acquired 100% of the direct and indirect legal and beneficial ownership of the shares of FPH Group Inc., a corporation incorporated pursuant to the laws of the Province of Ontario and the membership interests of Transtar International, LLC, a Michigan limited liability company, collectively “FPH”. The final purchase price for FPH was $41,316, including a measurement period adjustment during the three months ended June 30, 2023, resulting in a decrease to inventories of $1,080 an increase to purchase price of $276, and an increase to goodwill of $1,356. The final allocation of the purchase price paid for FPH is based on fair values of the assets acquired and liabilities assumed of FPH and is as follows (in thousands):

Cash and cash equivalents

    

$

1,755

Trade receivables

3,100

Inventories

3,496

Other assets, net

 

174

Property, plant, and equipment

 

624

Right of use assets

4,165

Intangible assets

22,611

Goodwill

 

15,840

Other current liabilities

(1,577)

Deferred revenue

(776)

Lease liabilities

(4,165)

Net deferred income tax liabilities

(3,931)

Net purchase price

$

41,316

On May 24, 2022, the Company acquired 100% of the outstanding stock of ThinGap, Inc. (“ThinGap”), a privately-owned California headquartered developer and manufacturer of high performance, zero cogging slotless motors for use in aerospace, defense, and medical applications that require precise performance in a compact, yet high-torque-to-volume solutions.

On June 17, 2022, the Company acquired 100% of the membership interests of Airex, LLC (“Airex”), a privately-owned New Hampshire headquartered developer of high precision electromagnetic components and solutions for the aerospace and defense, life sciences, semiconductor, and commercial industrial applications. The purchase price, collectively, for ThinGap and Airex was $16,618.

There were no additional measurement period adjustments during the six months ended June 30, 2023 related to the ThinGap and Airex acquisitions. The purchase price allocations of each of these acquisitions are final.

The December 30, 2021 acquisition of Spectrum Controls, Inc. (“Spectrum Controls”) included two deferred acquisition payments of which $12,500 (comprised of 50% cash and 50% Company stock) was paid in January 2023. One remaining payment of $12,500 is to be paid no later than January 3, 2024, comprised 50% cash and 50% in Company stock. As of September 30, 2023, $12,472 is included in accrued liabilities on the condensed consolidated balance sheet. As of December 31, 2022, $12,500 is included in accrued liabilities and $12,277 is included in other long-term liabilities on the condensed consolidated balance sheet.

6

Table of Contents

ALLIENT INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

The following pro forma financial information presents the combined resulted of operations if the FPH, ThinGap, and Airex acquisitions had occurred as of January 1, 2021:

Three months ended

Nine months ended

September 30, 

September 30, 

    

2022

    

2022

Revenues

$

134,405

$

382,727

Income before income taxes

$

9,693

$

22,766

The pro forma information includes certain adjustments, including depreciation and amortization expense, interest expense, and certain other adjustments, together with related income tax effects. The pro forma amounts do not reflect adjustments for anticipated operating efficiencies that the Company expected to or has subsequently achieved as a result of these acquisitions. The pro forma financial information is for informational purposes only and does not purport to present what the Company’s results would have been had these transactions actually occurred on the date presented or to project the combined company’s results of operations or financial position for future periods.

3.    REVENUE RECOGNITION

Performance Obligations

The Company considers control of most products to transfer at a single point in time when control is transferred to the customer, generally when the products are shipped in accordance with an agreement and/or purchase order. Control is defined as the ability to direct the use of and obtain substantially all of the remaining benefits of the product.

The Company satisfies its performance obligations under a contract with a customer by transferring goods and services in exchange for monetary consideration from the customer. The Company considers the customer’s purchase order, and the Company’s corresponding sales order acknowledgment as the contract with the customer. For some customers, control, and a sale, is transferred at a point in time when the product is delivered to a customer. For a limited number of contracts, for which revenue derived is not material in the periods presented, the Company recognizes revenue over time in proportion to costs incurred.

Sales, value add, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue.

Nature of Goods and Services

The Company designs, manufactures, and sells precision motion, control, power, and structural components to provide integrated system solutions as well as individual products to end customers and original equipment manufacturers (“OEM’s”) through the Company’s own direct sales force and authorized manufacturers’ representatives and distributors. The Company’s products include brushed and brushless DC motors, brushless servo and torque motors, coreless DC motors, integrated brushless motor-drives, gearmotors, gearing, modular digital servo drives, motion controllers, incremental and absolute optical encoders, active and passive filters for power quality and harmonic issues, and other controlled motion-related products. The Company’s target markets include Industrial, Vehicle, Medical, and Aerospace & Defense. 

Determining the Transaction Price

The majority of the Company’s contracts have an original duration of less than one year. For these contracts, the Company applies the practical expedient and therefore does not consider the effects of the time value of money. For multiyear contracts, the Company uses judgment to determine whether there is a significant financing component. These contracts are generally those in which the customer has made an up-front payment. Contracts that management determines to include a significant financing component are discounted at the Company’s incremental borrowing rate. The Company incurs interest expense and accrues a contract liability. As the Company satisfies performance obligations and recognizes revenue from these contracts, interest expense is recognized simultaneously. Management does not have any contracts that include a significant financing component as of September 30, 2023 and December 31, 2022.

7

Table of Contents

ALLIENT INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

Disaggregation of Revenue

The Company disaggregates revenue from contracts with customers into geographical regions and target markets. The Company determines that disaggregating revenue into these categories achieves the disclosure objective to depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. As noted below in Note 18, Segment Information, the Company’s business consists of one reportable segment. Revenue by geographic region is based on point of shipment origin.

A disaggregation of revenue by target market and geography is provided below:

Three months ended

Nine months ended

September 30, 

September 30, 

Target Market

    

2023

    

2022

    

2023

    

2022

Industrial

$

64,921

$

49,134

$

193,766

$

142,044

Vehicle

32,989

35,342

98,559

100,479

Medical

 

21,693

 

21,958

 

66,254

 

63,471

Aerospace & Defense

 

19,972

 

21,510

 

60,237

 

48,103

Distribution and Other

 

5,744

 

6,461

 

18,821

 

17,815

Total

$

145,319

$

134,405

$

437,637

$

371,912

Three months ended

Nine months ended

September 30, 

September 30, 

Geography

    

2023

    

2022

    

2023

    

2022

North America (primarily U.S.)

$

102,502

$

92,896

$

300,834

$

249,329

Europe

 

35,456

 

31,901

 

113,679

 

97,771

Asia-Pacific

 

7,361

 

9,608

 

23,124

 

24,812

Total

$

145,319

$

134,405

$

437,637

$

371,912

Contract Balances

When the timing of the Company’s delivery of product is different from the timing of the payments made by customers, the Company recognizes either a contract asset (performance precedes customer payment) or a contract liability (customer payment precedes performance). Typically, contracts are paid in arrears and are recognized as receivables after the Company considers whether a significant financing component exists.

The opening and closing balances of the Company’s contract liabilities are as follows:

    

September 30, 

December 31,

2023

2022

Contract liabilities in accrued liabilities

$

2,701

$

4,807

Contract liabilities in other long-term liabilities

11

19

$

2,712

$

4,826

The difference between the opening and closing balances of the Company’s contract liabilities primarily results from the timing difference between the Company’s performance and the customer’s payment. In the nine months ended September 30, 2023 and 2022, the Company recognized revenue of $4,053 and $2,217, respectively, that was included in the opening contract liabilities balance.

Significant Payment Terms

The Company’s contracts with its customers state the final terms of the sale, including the description, quantity, and price of each product or service purchased. Payments are typically due in full within 30-60 days of delivery. Since the customer agrees to a stated rate and price in the contract that do not vary over the contract, the majority of contracts do not contain variable consideration.

8

Table of Contents

ALLIENT INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

Returns, Refunds, and Warranties

In the normal course of business, the Company does not accept product returns unless the item is defective as manufactured. The Company establishes provisions for estimated returns and warranties. All contracts include a standard warranty clause to guarantee that the product complies with agreed specifications.

4.    INVENTORIES

Inventories include costs of materials, direct labor and manufacturing overhead, and are stated at the lower of cost (first-in, first-out basis) or net realizable value, as follows:

    

September 30, 

    

December 31, 

2023

2022

Parts and raw materials

$

85,633

$

89,100

Work-in-process

 

11,678

 

11,686

Finished goods

 

19,980

 

16,322

$

117,291

$

117,108

5.    PROPERTY, PLANT AND EQUIPMENT

Property, plant, and equipment is classified as follows:

    

September 30, 

    

December 31, 

2023

2022

Land

$

963

$

965

Building and improvements

 

 

25,689

 

25,093

Machinery, equipment, tools and dies

 

 

96,682

 

89,144

Construction work in progress

11,253

14,197

Furniture, fixtures and other

 

 

24,234

 

22,461

 

158,821

 

151,860

Less accumulated depreciation

 

(90,926)

 

(83,220)

Property, plant, and equipment, net

$

67,895

$

68,640

Depreciation expense was $3,346 and $3,135 for the three months ended September 30, 2023 and 2022, respectively. For the nine months ended September 30, 2023 and 2022, depreciation expense was $9,730 and $9,539, respectively.

6.    GOODWILL

The change in the carrying amount of goodwill for the nine months ended September 30, 2023 is as follows:

September 30, 

2023

Beginning balance

$

126,366

Goodwill acquired

2,923

Impact of measurement period adjustments of acquisitions (Note 2)

1,356

Effect of foreign currency translation

 

(347)

Ending balance

$

130,298

9

Table of Contents

ALLIENT INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

7.    INTANGIBLE ASSETS

Intangible assets on the Company’s condensed consolidated balance sheets consist of the following:

September 30, 2023

December 31, 2022

    

    

Gross

    

Accumulated

    

Net Book

    

Gross

    

Accumulated

    

Net Book

Life

Amount

Amortization

Value

Amount

Amortization

Value

Customer lists

 

5 – 18 years

$

116,184

$

(40,156)

$

76,028

$

112,378

$

(34,377)

$

78,001

Trade name

 

10 – 19 years

 

15,441

 

(7,676)

 

7,765

 

15,320

 

(6,900)

 

8,420

Design and technologies

 

10 – 15 years

 

41,129

 

(11,131)

 

29,998

 

41,212

 

(8,558)

 

32,654

Total

$

172,754

$

(58,963)

$

113,791

$

168,910

$

(49,835)

$

119,075

Amortization expense for intangible assets was $3,075 and $3,054 for the three months ended September 30, 2023 and 2022, respectively. For the nine months ended September 30, 2023 and 2022, amortization expense was $9,226 and $8,133, respectively.

Estimated future intangible asset amortization expense as of September 30, 2023 is as follows:

Year ending December 31, 

    

Total

Estimated

    

Amortization Expense

Remainder of 2023

$

3,044

2024

 

12,144

2025

12,129

2026

 

12,032

2027

11,589

Thereafter

 

62,853

Total estimated amortization expense

$

113,791

8.    STOCK-BASED COMPENSATION

Stock Incentive Plans

The Company’s Stock Incentive Plans provide for the granting of stock awards, including restricted stock, stock options and stock appreciation rights, to employees and non-employees, including directors of the Company.

Restricted Stock

For the nine months ended September 30, 2023, 123,601 shares of unvested restricted stock were awarded at a weighted average market value of $41.53. Of the restricted shares granted, 74,495 shares have performance-based vesting conditions. The value of the shares expected to vest is amortized to compensation expense over the related service period, which is normally three years, or over the estimated performance period. Shares of unvested restricted stock are generally forfeited if a recipient leaves the Company before the vesting date. Shares that are forfeited become available for future awards.

The following is a summary of restricted stock activity for the nine months ended September 30, 2023:

Number of

    

shares

Outstanding at beginning of period

 

403,974

Awarded

 

123,601

Vested

 

(129,541)

Forfeited

 

(21,034)

Outstanding at end of period

 

377,000

10

Table of Contents

ALLIENT INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

Stock-based compensation expense, net of forfeitures, was $1,354 and $1,262 was recorded for the three months ended September 30, 2023 and 2022, respectively. For the nine months ended September 30, 2023 and 2022, stock based compensation expense, net of forfeitures, was $4,165 and $3,752, respectively.

9.    ACCRUED LIABILITIES

Accrued liabilities consist of the following:

September 30, 

December 31, 

    

2023

    

2022

Compensation and fringe benefits

$

15,396

$

15,818

Accrued business acquisition consideration

 

12,657

 

12,500

Warranty reserve

 

2,284

 

2,160

Income taxes payable

1,454

3,934

Operating lease liabilities – current

5,100

4,224

Finance lease obligations – current

403

377

Contract liabilities

2,701

4,807

Contingent consideration

4,960

Other accrued expenses

 

7,282

 

4,301

$

52,237

$

48,121

10.    DEBT OBLIGATIONS

Debt obligations consisted of the following:

September 30, 

December 31, 

    

2023

    

2022

Long-term Debt

Revolving Credit Facility, long-term (1)

$

216,052

$

227,060

Unamortized debt issuance costs

(400)

(625)

Finance lease obligations – noncurrent

8,712

9,019

Long-term debt

$

224,364

$

235,454

(1)

The effective rate of the Amended Revolving Facility is 5.10% at September 30, 2023.

Amended Revolving Credit Facility

The Second Amended and Restated Credit Agreement (the “Amended Credit Agreement”), effective August 23, 2022, includes a $280 million revolving credit facility (the “Amended Revolving Facility”). In the Amended Credit Agreement, the referenced index was amended to the Term Standard Overnight Financing Rate (“SOFR”), whereas the previous credit agreement utilized the London Interbank Offering Rate (LIBOR) as the referenced interest rate. The Amended Credit Agreement has a maturity date of February 2025.

Borrowings under the Amended Revolving Facility bear interest at an annual rate equal to the Adjusted SOFR (as defined in the Amended Credit Agreement) which is subject to a floor of 0.00% plus an applicable margin spread ranging from 1.00% to 2.25% (1.625% at September 30, 2023) based on the Company’s ratio of total funded indebtedness to consolidated trailing twelve-month EBITDA (the “Total Leverage Ratio”). In addition, the Company is required to pay a commitment fee of between 0.10% and 0.275% annually on the unused portion of the Amended Revolving Facility, also based on the Company’s Total Leverage Ratio. The Amended Revolving Facility is secured by substantially all of the Company’s non-realty assets and is fully and unconditionally guaranteed by certain of the Company’s subsidiaries.

11

Table of Contents

ALLIENT INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

The Amended Credit Agreement includes covenants and restrictions that limit the Company’s ability to incur additional indebtedness, make certain investments, create, incur or assume certain liens, merge, consolidate or sell all or substantially all of its assets and enter into transactions with an affiliate of the Company on other than an arms’ length transaction. These covenants, which are described more fully in the Amended Credit Agreement, to which reference is made for a complete statement of the covenants, are subject to certain exceptions.  The Amended Credit Agreement contains financial covenants that require that the Company maintain a minimum interest coverage ratio of at least 3.0 to 1.0 at the end of each fiscal quarter. In addition, the Company’s Leverage Ratio at the end of any fiscal quarter shall not be greater than 4.0 to 1.0 ratio (reduced to 3.5:1.0 for quarters ending on or after December 31, 2023); provided that the Company may elect to temporarily increase the Leverage Ratio by 0.5x during the twelve-month period following a material acquisition under the Amended Credit Agreement (“acquisition leverage increase”), subject to certain exceptions.  The Company was in compliance with all covenants as of September 30, 2023.

As of September 30, 2023, the unused Amended Revolving Facility was $63,948. The amount available to borrow may be limited by the Company’s debt and EBITDA levels, which impacts its covenant calculations.

11.    DERIVATIVE FINANCIAL INSTRUMENTS

The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, and foreign exchange risk primarily through the use of derivative financial instruments.

The Company enters into foreign currency contracts with 30-day maturities to hedge its short-term balance sheet exposure, primarily intercompany, that are denominated in currencies (Euro, Mexican Peso, New Zealand Dollar, Chinese Renminbi, Swedish Krona, Canadian Dollar) other than the subsidiary’s functional currency and are adjusted to current values using period-end exchange rates. The resulting gains or losses are recorded in other expense, net in the condensed consolidated statements of income and comprehensive (loss) income. To minimize foreign currency exposure, the Company had foreign currency contracts with notional amounts of $20,851 and $18,891 at September 30, 2023 and December 31, 2022, respectively. The foreign currency contracts are recorded in the condensed consolidated balance sheets at fair value and resulting gains or losses are recorded in other expense, net in the condensed consolidated statements of income and comprehensive income (loss). During the three and nine months ended September 30, 2023, the Company had losses of $174 and $270, respectively, and during the three and nine months ended September 30, 2022, the Company had losses of $82 and $149, respectively, on foreign currency contracts which is included in other expense, net and generally offset the gains or losses from the foreign currency adjustments on the intercompany balances that are also included in other expense, net.

The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements on its variable-rate debt. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. In March 2020, the Company entered into two interest rate swaps with a combined notional amount of $20,000 that increased to $60,000 in March 2022 and matures in December 2024. In March 2022 the Company entered into an additional interest rate swap with a notional amount of $40,000 that matures in December 2026. In March 2023, the Company executed amendments to the existing swaps to amend the index on the interest rate derivatives from LIBOR to SOFR, in line with the existing Amended Revolving Facility. These amendments had no material financial impact to the Company’s operations or financial position.

The changes in the fair value of derivatives designated and that qualify as cash flow hedges is recorded in accumulated other comprehensive loss and is subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. During 2023 and 2022, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt.

The Company estimates that $4,008 will be reclassified as a decrease to interest expense over the next twelve months related to its interest rate derivatives. The Company does not use derivatives for trading or speculative purposes.

12

Table of Contents

ALLIENT INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the condensed consolidated balance sheets as of September 30, 2023 and December 31, 2022:

Asset Derivatives

Fair value as of:

Derivatives designated as

Balance Sheet

September 30, 

December 31, 

hedging instruments

    

Location

    

2023

    

2022

Foreign currency contracts

Prepaid expenses and other assets

$

25

$

48

Interest rate swaps

Other long-term assets

6,452

7,236

$

6,477

$

7,284

Liability Derivatives

Fair value as of:

Derivatives designated as

Balance Sheet

September 30, 

December 31, 

hedging instruments

    

Location

    

2023

    

2022

Foreign currency contracts

Accrued liabilities

$

7

$

The tables below present the effect of cash flow hedge accounting on other comprehensive income (loss) (“OCI”) for the three and nine months ended September 30, 2023 and 2022:

Amount of pre-tax gain recognized

Amount of pre-tax gain recognized

in OCI on derivatives

in OCI on derivatives

Derivatives in cash flow hedging relationships

Three months ended September 30, 

Nine months ended September 30, 

    

2023

    

2022

    

2023

    

2022

    

Interest rate swaps

$

790

$

2,916

$

1,995

$

7,335

Amount of pre-tax gain (loss) reclassified

Amount of pre-tax gain (loss) reclassified

from accumulated OCI into income

from accumulated OCI into income

Location of gain (loss) reclassified

Three months ended September 30, 

Nine months ended September 30, 

from accumulated OCI into income

2023

2022

    

2023

    

2022

Interest expense

$

1,014

$

229

$

2,854

$

(59)

The table below presents the line items that reflect the effect of the Company’s derivative financial instruments on the condensed consolidated statements of income and comprehensive income (loss) for the three and nine months ended September 30, 2023 and 2022:

Total amounts of income and expense

Total amounts of income and expense

line items presented that reflect the

line items presented that reflect the

effects of cash flow hedges recorded

effects of cash flow hedges recorded

Three months ended September 30, 

Nine months ended September 30, 

Derivatives designated as hedging instruments

    

Income Statement Location

    

2023

    

2022

    

2023

    

2022

Interest rate swaps

 

Interest Expense

$

3,164

$

2,337

$

9,309

$

4,900

The tables below present a gross presentation, the effects of offsetting, and a net presentation of the Company’s derivatives as of September 30, 2023 and December 31, 2022. The net amounts of derivative assets or liabilities can be reconciled to the tabular disclosure of fair value. The tabular disclosure of fair value provides the location that derivative assets and liabilities are presented in the condensed consolidated balance sheets:

13

Table of Contents

ALLIENT INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

Derivative assets:

Net amounts

Gross amounts

of assets

Gross amounts not offset in the consolidated 

As of 

Gross amounts

offset in the

presented in the

balance sheets

September 30, 

of recognized

consolidated

consolidated

Financial

Cash collateral

2023

    

assets

    

balance sheets

    

balance sheets

    

instruments

    

received

    

Net amount

Derivatives

$

6,477

$

$

6,477

$

$

$

6,477

Net amounts

Gross amounts

of assets

Gross amounts not offset in the consolidated 

As of 

Gross amounts

offset in the

presented in the

balance sheets

December 31, 

of recognized

consolidated

consolidated

Financial

Cash collateral

2022

    

assets

    

balance sheets

    

balance sheets

    

instruments

    

received

    

Net amount

Derivatives

$

7,284

$

$

7,284

$

$

$

7,284

Derivative liabilities:

Net amounts

Gross amounts

of liabilities

Gross amounts not offset in the consolidated 

As of 

Gross amounts

offset in the

presented in the

balance sheets

September 30, 

of recognized

consolidated

consolidated

Financial

Cash collateral

2023

    

liabilities

    

balance sheets

    

balance sheets

    

instruments

    

received

    

Net amount

Derivatives

$

$

$

7

$

$

$

7

Net amounts

Gross amounts

of liabilities

Gross amounts not offset in the consolidated 

As of 

Gross amounts

offset in the

presented in the

balance sheets

December 31, 

of recognized

consolidated

consolidated

Financial

Cash collateral

2022

    

liabilities

    

balance sheets

    

balance sheets

    

instruments

    

received

    

Net amount

Derivatives

$

$

$

$

$

$

The Company has agreements with each of its derivative counterparties that contain a provision where if the Company either defaults or is capable of being declared in default on any of its indebtedness, then the Company could also be declared in default on its derivative obligations.

12.   FAIR VALUE

Authoritative guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date.

The guidance establishes a framework for measuring fair value which utilizes observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. Preference is given to observable inputs.

These two types of inputs create the following three – level fair value hierarchy:

Level 1:

Quoted prices for identical assets or liabilities in active markets.

Level 2:

Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and model – derived valuations whose inputs or significant value drivers are observable.

Level 3:

Significant inputs to the valuation model that are unobservable.

14

Table of Contents

ALLIENT INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

The Company’s financial assets and liabilities include cash and cash equivalents, accounts receivable, debt obligations, accounts payable, and accrued liabilities. The carrying amounts reported in the condensed consolidated balance sheets for these assets and liabilities approximate their fair value because of the immediate or short-term maturities of these financial instruments.

The following tables presents the Company’s financial assets that are accounted for at fair value on a recurring basis as of September 30, 2023 and December 31, 2022, respectively, by level within the fair value hierarchy:

September 30, 2023

    

Level 1

    

Level 2

    

Level 3

Assets (liabilities)

Pension plan assets

$

5,431

$

$

Deferred compensation plan assets

 

3,989

 

 

Foreign currency hedge contract assets

25

Foreign currency hedge contract liabilities

 

 

(7)

 

Interest rate swaps, net

 

 

6,452

 

Contingent consideration

 

 

 

(5,930)

December 31, 2022

    

Level 1

    

Level 2

    

Level 3

Assets (liabilities)

Pension plan assets

$

5,324

$

$

Deferred compensation plan assets

 

3,870

 

 

Foreign currency hedge contracts

 

 

48

 

Interest rate swaps, net

 

 

7,236

 

Contingent consideration

 

 

 

(4,100)

The contingent consideration fair value measurement represents amounts in connection with the acquisitions of Sierramotion, which has a maximum amount of $2,000 and ALIO Industries (“ALIO”), which does not have a maximum amount. The measurements are based on significant inputs not observable in the market and therefore constitute Level 3 inputs within the fair value hierarchy. The Company determines the initial fair value of contingent consideration liabilities using a Monte Carlo valuation model, which involves a simulation of future earnings generated during the earn-out period using management’s best estimates, or a probability-weighted discounted cash flow analysis. The contingent consideration for the acquisition of Sierramotion consists of Company stock and, if earned, would be settled in the first half of 2024. The contingent consideration of ALIO is settled 50% in Company stock and 50% cash, the current portion of which is expected to be settled in the first half of 2024. Changes to contingent consideration since December 31, 2022 include a $1,960 increase due to current period acquisition activity and a reduction of $130 of the estimated fair value of contingent consideration during the three and nine months ended September 30, 2023 related to updated inputs to the timing of anticipated earnings of the acquired entity. Of the total contingent consideration, $4,960 is payable, if earned, within the next twelve months and is included in accrued liabilities and $970 is payable, if earned, in the first half of 2025 and included in other long-term liabilities on the condensed consolidated balance sheet as of September 30, 2023. Contingent consideration of $4,100 is included in other long-term liabilities as of December 31, 2022.

13.    INCOME TAXES

The income tax provision for interim periods is determined using an estimate of the annual effective tax rate, adjusted for discrete items, if any, that are taken into account in the relevant period. Each quarter, the estimate of the annual effective tax rate is updated, and if the estimated effective tax rate changes, a cumulative adjustment is made. There is potential for volatility of the effective tax rate due to several factors, including changes in the mix of the pre-tax income and the jurisdictions to which it relates, changes in tax laws, settlements with taxing authorities and foreign currency fluctuations.

The effective income tax rate was 23.1% and 27.5% for the three months ended September 30, 2023 and 2022, respectively. The effective tax rate for both the three months ended September 30, 2023 and 2022 does not include any discrete tax items that had a significant impact on tax rates. For the nine months ended September 30, 2023 and 2022, the effective income tax rate was 23.4% and 26.3%, respectively. The effective tax rate for the nine months ended September 30, 2023 and September 30, 2022 includes discrete tax benefits of (1.5%) and (1.7%), respectively, related primarily to share-based awards and the reversal of prior year uncertain tax positions.

15

Table of Contents

ALLIENT INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

14.    LEASES

The Company has operating leases for office space, manufacturing facilities and equipment, computer equipment and automobiles. Many leases include one or more options to renew, some of which include options to extend the leases for a long-term period, and some leases include options to terminate the leases within 30 days. In certain of the Company’s lease agreements, the rental payments are adjusted periodically to reflect actual charges incurred for capital area maintenance, utilities, inflation and/or changes in other indexes.

Supplemental cash flow information related to the Company’s operating and finance leases for the nine months ended September 30, 2023 and 2022 was as follows:

September 30, 

2023

2022

Cash paid for operating leases

    

$

4,195

    

$

3,884

  

Cash paid for interest on finance lease obligations

    

$

318

    

$

329

  

Assets acquired under operating leases

$

6,578

$

8,133

Assets acquired under finance leases

$

$

5,053

ROU assets obtained in acquisitions

$

224

$

9,471

The Company’s finance lease obligations relate to a manufacturing facility. Finance lease assets of $8,366 and $8,839 as of September 30, 2023 and December 31, 2022, respectively, are included in property, plant and equipment, net. As of September 30, 2023, finance lease obligations of $403 are included in accrued liabilities and $8,712 are included in long-term debt on the condensed consolidated balance sheet. As of December 31, 2022, finance lease obligations of $377 are included in accrued liabilities and $9,019 are included in long-term debt on the condensed consolidated balance sheet

The following table presents the maturity of the Company’s operating and finance lease liabilities as of September 30, 2023:

    

Operating Leases

Finance Leases

Remainder of 2023

    

1,561

266

2024

 

5,878

 

815

2025

 

4,860

 

831

2026

4,280

848

2027

3,675

867

Thereafter

 

8,493

 

8,770

Total undiscounted cash flows

$

28,747

$

12,397

Less: present value discount

(3,356)

(3,216)

Total lease liabilities

$

25,391

$

9,181

The Company has operating leases certain facilities from companies for which a member of management is a part owner. In connection with such leases, the Company made fixed minimum lease payments to the lessor of $242 and $706 during the three and nine months ended September 30, 2023 and is obligated to make payments of $404 during the remainder of 2023. Future fixed minimum lease payments under these leases as of September 30, 2023 are $11,433.

16

Table of Contents

ALLIENT INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

15.    ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME

Accumulated Other Comprehensive (Loss) Income (“AOCI”) for the three months ended September 30, 2023 and 2022 is comprised of the following:

Foreign Currency

Defined Benefit

Tax Effect of

Translation

    

Plan Liability

    

Cash Flow Hedges

    

Cash Flow Hedges

    

Adjustment

    

Total

At June 30, 2023

$

(594)

$

6,675

$

(1,545)

$

(15,997)

$

(11,461)

Unrealized gain (loss) on cash flow hedges

790

(189)

601

Amounts reclassified from AOCI

(1,014)

243

(771)

Foreign currency translation loss

(2,923)

(2,923)

At September 30, 2023

$

(594)

$

6,451

$

(1,491)

$

(18,920)

$

(14,554)

Foreign Currency

Defined Benefit

Tax Effect of

Translation

    

Plan Liability

    

Cash Flow Hedges

    

Cash Flow Hedges

    

Adjustment

    

Total

At June 30, 2022

$

(863)

$

4,928

$

(1,173)

$

(17,341)

$

(14,449)

Unrealized gain (loss) on cash flow hedges

2,916

(700)

2,216

Amounts reclassified from AOCI

(229)

55

(174)

Foreign currency translation loss

(9,603)

(9,603)

At September 30, 2022

$

(863)

$

7,615

$

(1,818)

$

(26,944)

$

(22,010)

AOCI for the nine months ended September 30, 2023 and 2022 is comprised of the following:

Foreign Currency

Defined Benefit

Tax Effect of

Translation

    

Plan Liability

    

Cash Flow Hedges

    

Cash Flow Hedges

    

Adjustment

    

Total

At December 31, 2022

$

(594)

$

7,310

$

(1,754)

$

(16,925)

$

(11,963)

Unrealized gain (loss) on cash flow hedges

1,995

(455)

1,540

Amounts reclassified from AOCI

(2,854)

718

(2,136)

Foreign currency translation loss

(1,995)

(1,995)

At September 30, 2023

$

(594)

$

6,451

$

(1,491)

$

(18,920)

$

(14,554)

Foreign Currency

Defined Benefit

Tax Effect of

Translation

    

Plan Liability

    

Cash Flow Hedges

    

Cash Flow Hedges

    

Adjustment

    

Total

At December 31, 2021

$

(863)

$

221

$

(41)

$

(7,409)

$

(8,092)

Unrealized gain (loss) on cash flow hedges

7,335

(1,762)

5,573

Amounts reclassified from AOCI

59

(15)

44

Foreign currency translation loss

(19,535)

(19,535)

At September 30, 2022

$

(863)

$

7,615

$

(1,818)

$

(26,944)

$

(22,010)

The realized gains and losses relating to the Company’s interest rate swap hedges were reclassified from AOCI and included in interest expense in the condensed consolidated statements of income and comprehensive income.

17

Table of Contents

ALLIENT INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

16.    DIVIDENDS PER SHARE

The Company declared a quarterly dividend of $0.03 per share in the third and second quarters of 2023 and $0.025 per share in first quarter of 2023 and each of the first, second, and third quarters of 2022. Total dividends declared were $1,373 and $1,174 in the nine months ended September 30, 2023 and 2022, respectively.

17.    EARNINGS PER SHARE

Basic and diluted weighted-average shares outstanding are as follows:

Three months ended

Nine months ended

September 30, 

September 30, 

   

2023

    

2022

    

2023

    

2022

    

Basic weighted average shares outstanding

 

15,979

 

15,661

 

15,940

 

15,373

 

Dilutive effect of potential common shares

 

258

 

508

 

258

 

556

 

Diluted weighted average shares outstanding

 

16,237

 

16,169

 

16,198

 

15,929

 

For the three and nine months ended September 30, 2023 and 2022, the anti-dilutive common shares excluded from the calculation of diluted earnings per share were immaterial.

18.    SEGMENT INFORMATION

The Company operates in one segment for the manufacture and marketing of specialty-controlled motion products and solutions for end user and OEM applications. The Company’s chief operating decision maker is the Chief Executive Officer, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services in which the entity holds material assets and reports revenue.

Revenue for the three months ended September 30, 2023 and 2022 was comprised of 61% and 59%, respectively, shipped to U.S. customers. For each of the nine months ended September 30, 2023 and 2022, revenues was comprised of 58% shipped to U.S. customers. The remainder of revenues for all periods were shipped to foreign customers, primarily in Europe, Canada, and Asia-Pacific.

Identifiable foreign fixed assets were $35,708 and $34,879 as of September 30, 2023 and December 31, 2022, respectively. Identifiable assets outside of the U.S. are attributable to Europe, China, Mexico, and Asia-Pacific.

For the three months ended September 30, 2023, one customer (Customer A) accounted for 14% of revenues and one customer (Customer B) accounted for 10% of revenues. Customer A and Customer B accounted for 11% and 10% of revenues, respectively, for the nine months ended September 30, 2023. For the three and nine months ended September 30, 2022, Customer B accounted for 11% and 12% of revenues, respectively. As of September 30, 2023, Customer A represented 18% of trade receivables.

18

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

All statements contained herein that are not statements of historical fact constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance, or achievements, and may contain the word “believe,” “anticipate,” “expect,” “project,” “intend,” “will continue,” “will likely result,” “should” or words or phrases of similar meaning. Forward-looking statements involve known and unknown risks and uncertainties that may cause actual results to differ materially from the expected results described in the forward-looking statements. The risks and uncertainties include those associated with: the domestic and foreign general business and economic conditions in the markets we serve, including political and currency risks and adverse changes in local legal and regulatory environments; the severity, magnitude and duration of the impact of COVID-19, including impacts from businesses’ and governments’ responses to the ongoing impact on our operations and personnel, and on commercial activity and demand across our and our customers’ businesses, and on global supply chains; our inability to predict the extent to which COVID-19 and related impacts will continue to adversely impact our business operations, financial performance, results of operations, financial position, the prices of our securities and the achievement of our strategic objectives; the geopolitical conflicts and their ability to create instability and economic uncertainty; the introduction of new technologies and the impact of competitive products; the ability to protect the Company’s intellectual property; our ability to sustain, manage or forecast our growth and product acceptance to accurately align capacity with demand; the continued success of our customers and the ability to realize the full amounts reflected in our order backlog as revenue; the loss of significant customers or the enforceability of the Company’s contracts in connection with a merger, acquisition, disposition, bankruptcy, or otherwise; our ability to meet the technical specifications of our customers; the performance of subcontractors or suppliers and the continued availability of parts and components; failure of a key information technology system, process or site or a breach of information security, including a cybersecurity breach, ransomware, or failure of one or more key information technology systems, networks, processes, associated sites or service providers; changes in government regulations; the availability of financing and our access to capital markets, borrowings, or financial transactions to hedge certain risks; the ability to attract and retain qualified personnel, and in particular those who can design new applications and products for the motion industry; the ability to implement our corporate strategies designed for growth and improvement in profits including to identify and consummate favorable acquisitions to support external growth and the development of new technologies; the ability to successfully integrate an acquired business into our business model without substantial costs, delays, or problems; our ability to control costs, including the establishment and operation of low cost region manufacturing and component sourcing capabilities; and in the Company’s Annual Report in Form 10-K. Actual results, events and performance may differ materially from the Company’s forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements as a prediction of actual results. Any forward-looking statement speaks only as of the date on which it is made. New risks and uncertainties arise over time, and it is not possible for us to predict the occurrence of those matters or the manner in which they may affect us. The Company has no obligation or intent to release publicly any revisions to any forward-looking statements, whether as a result of new information, future events, or otherwise.

New risk factors emerge from time to time, and it is not possible for management to predict all such risk factors, nor can it assess the impact of all such risk factors on its business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The Company’s expectations, beliefs and projections are believed to have a reasonable basis; however, the Company makes no assurance that expectations, beliefs, or projections will be achieved.

Overview

Effective August 23, 2023, Allied Motion Technologies Inc. (“Allied Motion”) changed its name to Allient Inc. (“Allient” or the “Company”). In conjunction with the name change, Allient’s ticker symbol has changed from “AMOT” to “ALNT”. The name change reflects the Company’s evolution of its business to transform from a products-based business in motion control to a solutions-oriented company that addresses its customers’ requirements for Motion, Controls and Power technology for a multitude of applications.

We are a global company that designs, manufactures, and sells precision and specialty-controlled motion products and solutions used in a broad range of industries. Our target markets include Industrial, Vehicle, Medical, and Aerospace & Defense (A&D). We are headquartered in Amherst, NY, and have operations in the United States, Canada, Mexico, Europe, and Asia-Pacific. We are known worldwide for our expertise in electro-magnetic, mechanical, and electronic motion technology. We sell component and integrated controlled motion solutions to end customers and OEMs through our own direct sales force and authorized manufacturers’ representatives and distributors. Our products include nano precision positioning systems, servo control systems, motion controllers, digital servo amplifiers and drives, brushless servo, torque, and coreless motors, brush motors, integrated motor-drives, gear motors, gearing, incremental and absolute optical encoders, active (electronic) and passive (magnetic) filters for power quality and harmonic issues, Industrial safety rated input/output Modules, Universal Industrial Communications Gateways, light-weighting technologies, and other controlled motion-related products.

19

Table of Contents

Business Environment

Recent Events

The ongoing threat of COVID-19 has and will likely continue to create uncertainties and disruptions to the Company as well as the global economy. This has resulted in operational and financial challenges and risks. In response, we have implemented extensive additional health and safety protocols from time to time in keeping with governmental requirements and best practices. As a result of the continued threat of variants of the virus, and related global impacts, there are likely to be ongoing disruptions to certain supply chains as well as impacts on customer demand that may present additional challenges and volatility to our business.

During 2022 and into the first three quarters of 2023, inflation negatively impacted our input costs and pricing, primarily for labor and materials. We, our customers, and our suppliers are also experiencing the effect of a higher interest rate environment. Gross domestic product growth slowed throughout 2022 and continued into 2023 largely due to the widespread impacts of inflation, increasing interest rates, and more restrictive financial conditions. Supply chain disruptions, labor shortages, and global inflation remain persistent, as the level of geopolitical instability is elevating.

Specifically, the current geopolitical conflicts are creating higher levels of economic uncertainty and volatility with regard to energy prices, interest rates, our supply chain, and certain customer ordering patterns. We are closely monitoring the developments as they unfold in order to react accordingly. The impact of the conflicts on our operational and financial performance will depend on future developments that cannot be predicted. The Company does not believe the impact on our results to be material at this time.

The Company completed an acquisition of Sierramotion in the third quarter of 2023. Additionally, we completed three acquisitions during the second quarter 2022 and three acquisitions during the fourth quarter of 2021, (collectively the “recent acquisitions”). These recent acquisitions are important to executing on the Company’s strategic plan, and we remain focused in the near term will be on successfully integrating these acquisitions and leveraging the synergies that will be important drivers of our future growth and profitability.

20

Table of Contents

Operating Results

Three months ended September 30, 2023 compared to three months ended September 30, 2022

For the three months ended

    

2023 vs. 2022

September 30, 

Variance

 

(Dollars in thousands, except per share data)

    

2023

    

2022

$

    

%

Revenues

$

145,319

$

134,405

$

10,914

8

%

Cost of goods sold

 

97,821

91,108

 

6,713

7

%

Gross profit

 

47,498

 

43,297

 

4,201

10

%

Gross margin percentage

 

32.7

%  

 

32.2

%  

 

  

  

Operating costs and expenses:

 

  

 

  

 

  

  

Selling

 

6,021

5,497

 

524

10

%

General and administrative

 

14,642

13,148

 

1,494

11

%

Engineering and development

 

10,702

9,702

 

1,000

10

%

Business development

 

1,194

199

 

995

NM

%

Amortization of intangible assets

 

3,075

3,054

 

21

1

%

Total operating costs and expenses

 

35,634

 

31,600

 

4,034

13

%

Operating income

 

11,864

 

11,697

 

167

1

%

Interest expense

 

3,164

 

2,337

 

827

35

%

Other expense, net

 

42

 

243

 

(201)

(83)

%

Total other expense

 

3,206

 

2,580

 

626

24

%

Income before income taxes

 

8,658

 

9,117

 

(459)

(5)

%

Income tax provision

 

(1,992)

 

(2,508)

 

516

(21)

%

Net income

$

6,666

$

6,609

$

57

1

%

 

  

 

  

 

  

  

Effective tax rate

 

23.0

%  

 

27.5

%  

Diluted earnings per share

$

0.41

$

0.41

$

%

Bookings

$

154,908

$

126,158

$

28,750

23

%

Backlog

$

309,636

$

310,186

$

(550)

%

REVENUES: The increase in revenues during the third quarter 2023 reflects increases primarily within Industrial markets. Our revenue for the third quarter of 2023 was comprised of 61% to U.S. customers and 39% to customers primarily in Europe, Canada, and Asia-Pacific. The overall increase in revenue was due to a 7% volume increase as well as a 1% favorable currency impact. Organic growth was 7% during the third quarter 2023. See information included in “Non – GAAP Measures” below for a discussion of the non-GAAP measure and reconciliation of revenue to revenue excluding foreign currency impacts.

ORDER BOOKINGS AND BACKLOG: The 23% increase in bookings in the third quarter 2023 compared to 2022 is due primarily to a 22% increase in volume and a 1% favorable currency impact. The increase in bookings during the third quarter 2023 compared to 2022 is primarily due to timing on orders in the A&D markets.

GROSS PROFIT AND GROSS MARGIN: Gross profit increased to $47,498 in the third quarter of 2023 from $43,297 in the third quarter of 2022 driven by higher sales volume, and gross margins increased to 32.7% for 2023, compared to 32.2% for 2022. The increase in gross margin percentage was driven by cost absorption on higher sales volume, pricing, and favorable mix, notably from accretive acquisitions, when comparing the year to date periods.

SELLING EXPENSES: Selling expenses increased 10% during the third quarter of 2023 compared to 2022 primarily due to increased employee compensation related costs as well as sales commissions related to the increased revenue. Selling expenses as a percentage of revenues were 4% in each of the three months ended September 30, 2023 and 2022.

GENERAL AND ADMINISTRATIVE EXPENSES: General and administrative expenses increased by 11% during the third quarter 2023 compared to 2022 due primarily to employee compensation related costs. As a percentage of revenues, general and administrative expenses were 10% in the three months ended September 30, 2023 and 2022.

21

Table of Contents

ENGINEERING AND DEVELOPMENT EXPENSES: Engineering and development expenses increased by 10% in the third quarter 2023 compared to 2022. The increase is primarily due to the continued ramp up of development projects to meet the future needs of our target markets, as well as supporting growing customer application development needs. As a percentage of revenues, engineering and development expenses were 7% for the three months ended September 30, 2023 and 2022.

BUSINESS DEVELOPMENT COSTS: The increase in business development costs in the third quarter of 2023 compared to 2022 is largely due to manufacturing footprint rationalization, as well as costs incurred due to current period acquisition activities.

AMORTIZATION OF INTANGIBLE ASSETS: Amortization of intangible assets was largely flat in the third quarter 2023 compared to 2022.

INTEREST EXPENSE: Interest expense increased in the third quarter of 2023 compared to 2022 is substantially all due to higher interest rates. The increase in interest expense is partially offset by reductions to interest expense realized through our interest rate swaps.

INCOME TAXES: The effective income tax rate was 23.0% and 27.5% for the three months ended September 30, 2023 and 2022, respectively. The effective tax rate for each of the three months ended September 30, 2023 and 2022 does not include any significant discrete tax items. The lower effective tax rate in the third quarter of 2023 as compared to the third quarter of 2022 is primarily due to estimates of tax credits, the impacts of non-deductible transaction costs in the prior year period, and earnings mix. The Company expects its income tax rate for the full year 2023 to be approximately 23% to 25%.

NET INCOME AND ADJUSTED NET INCOME: Net income increased during the third quarter of 2023 compared to 2022, primarily reflecting our gross profit increase, and partially offset by inflationary pressures as well as an increase in interest expense.

ADJUSTED NET INCOME: For the quarters ended September 30, 2023 and 2022 was $9,980 and $9,683, respectively. Adjusted diluted earnings per share for the third quarter of 2023 and 2022 were $0.61 and $0.60, respectively. Adjusted net income and adjusted diluted earnings per share are non-GAAP measures. See information included in “Non–GAAP Measures” below for a discussion of the non-GAAP measure and reconciliation of net income to adjusted net income and diluted earnings per share to adjusted diluted earnings per share.

EBITDA AND ADJUSTED EBITDA: EBITDA was $18,243 for the third quarter of 2023 compared to $18,146 for the third quarter of 2022. Adjusted EBITDA was $20,849 and $19,864 for the third quarters of 2023 and 2022, respectively. EBITDA and Adjusted EBITDA are non-GAAP measures. EBITDA consists of income before interest expense, provision for income taxes, and depreciation and amortization. Adjusted EBITDA also excludes stock-based compensation expense, foreign currency gain/loss and certain other items. Refer to information included in “Non-GAAP Measures” below for a discussion of the non-GAAP measure and a reconciliation of net income to EBITDA and Adjusted EBITDA.

22

Table of Contents

Nine months ended September 30, 2023 compared to nine months ended September 30, 2022

For the nine months ended

    

2023 vs. 2022

September 30, 

Variance

 

(Dollars in thousands, except per share data)

    

2023

    

2022

$

    

%

Revenues

$

437,637

$

371,912

$

65,725

18

%

Cost of goods sold

 

298,328

 

255,381

 

42,947

17

%

Gross profit

 

139,309

 

116,531

 

22,778

20

%

Gross margin percentage

 

31.8

%  

 

31.3

%  

 

  

  

Operating costs and expenses:

 

  

 

  

 

  

  

Selling

 

18,354

 

16,336

 

2,018

12

%

General and administrative

 

43,624

 

37,239

 

6,385

17

%

Engineering and development

 

31,041

 

28,879

 

2,162

7

%

Business development

 

1,791

 

2,464

 

(673)

(27)

%

Amortization of intangible assets

 

9,226

 

8,133

 

1,093

13

%

Total operating costs and expenses

 

104,036

 

93,051

 

10,985

12

%

Operating income

 

35,273

 

23,480

 

11,793

50

%

Interest expense

 

9,309

 

4,900

 

4,409

90

%

Other expense, net

 

187

 

9

 

178

NM

%

Total other expense, net

 

9,496

 

4,909

 

4,587

93

%

Income before income taxes

 

25,777

 

18,571

 

7,206

39

%

Income tax provision

 

(6,027)

 

(4,878)

 

(1,149)

24

%

Net income

$

19,750

$

13,693

$

6,057

44

%

 

  

 

  

 

  

  

Effective tax rate

 

23.4

%  

 

26.3

%  

Diluted earnings per share

$

1.22

$

0.86

$

0.36

42

%

Bookings

$

415,113

$

420,662

$

(5,549)

(1)

%

Backlog

$

309,636

$

310,186

$

(550)

%

REVENUES: The increase in revenues for the year to date 2023 reflects increases in our Industrial and A&D served markets and includes the full year impact of the 2022 acquisitions. Our revenues for the period ended September 30, 2023 was comprised of 58% to U.S. customers and 42% to customers primarily in Europe, Canada and Asia-Pacific. The overall increase in revenue was due to a 18% volume increase as currency impact was insignificant. Organic growth was 16% during the year to date 2023. See information included in “Non – GAAP Measures” below for a discussion of the non-GAAP measure and reconciliation of revenue to revenue excluding foreign currency impacts.

ORDER BOOKINGS AND BACKLOG: Orders for the year to date 2023 compared to 2022 decreased 1%. This is primarily due to more normalization to pre COVID-19 order patterns in most served markets, offset by increases in A&D due to program timing.

GROSS PROFIT AND GROSS MARGIN: Gross profit increased to $139,309 for year to date 2023 from $116,531 in 2022 driven by higher sales volume, including the full period impact from the 2022 acquisitions, and gross margins increased to 31.8% for 2023, compared to 31.3% for 2022. The increase in gross margin percentage was driven by cost absorption on higher sales volume, pricing, and favorable mix, notably from accretive acquisitions, when comparing the year to date periods.

SELLING EXPENSES: Selling expenses increased 12% during year to date 2023 compared to 2022 primarily due to increased costs in connection with our recently completed acquisitions as well as sales commissions related to the increased revenue growth. Selling expenses as a percentage of revenues were comparable at 4% during year to date 2023 and 2022.

GENERAL AND ADMINISTRATIVE EXPENSES: General and administrative expenses increased by 17% during the nine months ended September 30, 2023 compared to the same period of 2022 due primarily to increased costs related to the inclusion of our 2022 acquisitions and increased incentive compensation driven by higher revenue and profitability. As a percentage of revenues, general and administrative expenses were 10% in 2023 and 2022.

23

Table of Contents

ENGINEERING AND DEVELOPMENT EXPENSES: Engineering and development expenses increased by 7% during the year to date 2023 compared to 2022. The increase is due primarily to the inclusion and nature of our recent acquisitions along with our continued investment in new product development. As a percentage of revenues, engineering and development expenses were 7% for the nine months ended September 30, 2023 and 2022.

BUSINESS DEVELOPMENT COSTS: The decrease in business development costs for year to date 2023 compared to 2022 is due to increased costs in the prior year due to the number of acquisitions completed in 2022 vs. 2023 and lower current period costs of manufacturing footprint rationalization.

AMORTIZATION OF INTANGIBLE ASSETS: Amortization of intangible assets increased for year to date 2023 compared to 2022 due to incremental intangible amortization attributable to the 2022 acquisitions.

INTEREST EXPENSE: Interest expense increased by 90% (or $4.4 million) for the year to date 2023 compared to 2022 primarily due to higher interest rates (contributing to $3.1 million of the increase), with the remainder due to higher average debt balances.

INCOME TAXES: For the nine months ended September 30, 2023 and 2022, the effective income tax rate was 23.4% and 26.3%, respectively. The effective tax rate includes a discrete tax benefit of (1.5%) and (1.7%), respectively, primarily related to the reversal of uncertain tax positions and share-based payment awards. The lower effective tax rate for year to date 2023 as compared to year to date 2022 is primarily due to estimates of tax credits, the impacts of non-deductible transaction costs in the prior year period, and earnings mix

NET INCOME AND ADJUSTED NET INCOME: Net income increased during year to date 2023 compared to 2022, due in large part to organic growth as well as from the recent acquisitions, as reflected primarily in our gross profit increase, and partially offset by higher operating expenses and costs driven by the recent acquisitions, inflationary pressures, subsequent increases to intangible amortization as well as an increase in interest expense.

Adjusted net income for the nine month periods ended September 30, 2023 and 2022 was $28,386 and $23,038, respectively. Adjusted diluted earnings per share for year to date 2023 and 2022 were $1.75 and $1.45, respectively. Adjusted net income and adjusted diluted earnings per share are non-GAAP measures. See information included in “Non–GAAP Measures” below for a discussion of the non-GAAP measure and reconciliation of net income to Adjusted net income and diluted earnings per share to Adjusted diluted earnings per share.

EBITDA AND ADJUSTED EBITDA: EBITDA was $54,042 for year to date 2023 compared to $42,693 for year to date 2022. Adjusted EBITDA was $60,255 and $48,963 for year to date 2023 and 2022, respectively. EBITDA and Adjusted EBITDA are non-GAAP measures. EBITDA consists of income before interest expense, provision for income taxes, and depreciation and amortization. Adjusted EBITDA also excludes stock-based compensation expense, foreign currency gain/loss and certain other items. Refer to information included in “Non-GAAP Measures” below for a discussion of the non-GAAP measure and a reconciliation of net income to EBITDA and Adjusted EBITDA.

Non-GAAP Measures

Revenue excluding foreign currency exchange impacts, EBITDA, Adjusted EBITDA, Adjusted net income and Adjusted diluted earnings per share are provided for information purposes only and are not measures of financial performance under GAAP. Management believes the presentation of these financial measures reflecting non-GAAP adjustments provides important supplemental information to investors and other users of our financial statements in evaluating the operating results of the Company as distinct from results that include items that are not indicative of ongoing operating results. In particular, those charges and credits that are not directly related to operating unit performance, and that are not a helpful measure of the performance of our underlying business particularly in light of their unpredictable nature. These non-GAAP disclosures have limitations as analytical tools, should not be viewed as a substitute for revenue and net income determined in accordance with GAAP, and should not be considered in isolation or as a substitute for analysis of the Company’s results as reported under GAAP, nor is it necessarily comparable to non-GAAP performance measures that may be presented by other companies. In addition, supplemental presentation should not be construed as an inference that the Company’s future results will be unaffected by similar adjustments to net income determined in accordance with GAAP. Organic growth is reported revenues adjusted for the impact of foreign currency and the revenue contribution from acquisitions.

24

Table of Contents

The Company believes that revenue excluding foreign currency exchange impacts is a useful measure in analyzing sales results. The Company excludes the effect of currency translation from revenue for this measure because currency translation is not fully under management’s control, is subject to volatility and can obscure underlying business trends. The portion of revenue attributable to currency translation is calculated as the difference between the current period revenue and the current period revenue after applying foreign exchange rates from the prior period.

The Company believes EBITDA is often a useful measure of a Company’s operating performance and is a significant basis used by the Company’s management to measure the operating performance of the Company’s business because EBITDA excludes charges for depreciation, amortization and interest expense that have resulted from our debt financings, acquisitions, as well as our provision for income tax expense. EBITDA is frequently used as one of the bases for comparing businesses in the Company’s industry.

The Company also believes that Adjusted EBITDA provides helpful information about the operating performance of its business. Adjusted EBITDA excludes stock-based compensation expense, as well as business development costs, foreign currency gains/losses on short-term assets and liabilities, and other items that are not indicative of the Company’s core operating performance. EBITDA and Adjusted EBITDA do not represent and should not be considered as an alternative to net income, operating income, net cash provided by operating activities or any other measure for determining operating performance or liquidity that is calculated in accordance with GAAP.

Management uses Adjusted net income and Adjusted diluted earnings per share to assess the Company’s consolidated financial and operating performance. Adjusted net income and Adjusted diluted earnings per share are provided for informational purposes only and are not a measure of financial performance under GAAP. These measures help management make decisions that are expected to facilitate meeting current financial goals as well as achieving optimal financial performance. Adjusted net income provides management with a measure of financial performance of the Company based on operational factors as it removes the impact of certain non-routine items from the Company’s operating results. Adjusted diluted earnings per share provides management with an indication of how Adjusted net income would be reflected on a per share basis for comparison to the GAAP diluted earnings per share measure. Adjusted net income is a key metric used by senior management and the Company’s board of directors to review the consolidated financial performance of the business. This measure adjusts net income determined in accordance with GAAP to reflect changes in financial results associated with the highlighted expense and income items.

The Company’s calculation of revenues excluding foreign currency exchange impacts for the three and nine months ended September 30, 2023 is as follows (in thousands):

    

Three months ended

Nine months ended

    

    

September 30, 2023

    

September 30, 2023

    

Revenue as reported

$

145,319

$

437,637

Currency impact (favorable) unfavorable

 

(1,793)

1,869

Revenue excluding foreign currency exchange impacts

$

143,526

$

439,506

The Company’s calculation of EBITDA and Adjusted EBITDA for the three and nine months ended September 30, 2023 and 2022 is as follows (in thousands):

    

Three months ended

    

Nine months ended

September 30, 

September 30, 

    

2023

    

2022

    

2023

    

2022

Net income as reported

$

6,666

$

6,609

$

19,750

$

13,693

Interest expense

 

3,164

 

2,337

 

9,309

 

4,900

Provision for income tax

 

1,992

 

2,508

 

6,027

 

4,878

Depreciation and amortization

 

6,421

 

6,692

 

18,956

 

19,222

EBITDA

 

18,243

 

18,146

 

54,042

 

42,693

Stock-based compensation expense

 

1,354

 

1,262

 

4,165

 

3,752

Business development costs

 

1,194

 

199

 

1,791

 

2,464

Foreign currency loss

58

257

257

54

Adjusted EBITDA

$

20,849

$

19,864

$

60,255

$

48,963

25

Table of Contents

The Company’s calculation of Adjusted net income and Adjusted diluted earnings per share for the three and nine months ended September 30, 2023 and 2022 is as follows (in thousands except per share amounts):

    

For the three months ended

September 30, 

    

    

Per diluted

    

    

Per diluted

2023

share

2022

share

Net income as reported

$

6,666

$

0.41

$

6,609

$

0.41

Non-GAAP adjustments, net of tax (1)

 

  

 

  

 

  

 

  

Amortization of intangible assets – net

 

2,355

0.14

 

2,725

 

0.17

Foreign currency loss – net

 

44

 

-

 

197

 

0.01

Business development costs – net

 

915

 

0.06

 

152

 

0.01

Non-GAAP adjusted net income and adjusted diluted earnings per share

$

9,980

$

0.61

$

9,683

$

0.60

(1)

Applies a blended federal, state, and foreign tax rate of approximately 23% applicable to the non-GAAP adjustments.

    

For the nine months ended

September 30, 

    

    

Per diluted

    

    

Per diluted

2023

share

2022

share

Net income as reported

$

19,750

$

1.22

$

13,693

$

0.86

Non-GAAP adjustments, net of tax (1)

 

  

 

  

 

  

 

  

Amortization of intangible assets – net

 

7,067

0.44

 

7,417

 

0.47

Foreign currency loss – net

 

197

 

0.01

 

41

 

-

Business development costs – net

 

1,372

 

0.08

 

1,887

 

0.12

Non-GAAP adjusted net income and adjusted diluted earnings per share

$

28,386

$

1.75

$

23,038

$

1.45

(1)

Applies a blended federal, state, and foreign tax rate of approximately 23% applicable to the non-GAAP adjustments.

Liquidity and Capital Resources

The Company’s liquidity position as measured by cash and cash equivalents decreased by $6,778 to a balance of $23,836 at September 30, 2023 from December 31, 2022.

    

2023 vs.

    

Nine Months Ended

2022

September 30, 

Variance

(in thousands):

    

2023

    

2022

    

$

    

Net cash provided by (used in) operating activities

$

27,132

$

(5,824)

$

32,956

Net cash used in investing activities

(18,854)

 

(55,622)

 

36,768

Net cash (used in) provided by financing activities

(14,500)

 

60,957

 

(75,457)

Effect of foreign exchange rates on cash

(556)

 

(2,269)

 

1,713

Net decrease in cash and cash equivalents

$

(6,778)

$

(2,758)

$

(4,020)

Of the $23,836 of cash and cash equivalents at September 30, 2023, $20,194 was located at our foreign subsidiaries and may be subject to withholding tax if repatriated back to the U.S.

During the nine months ended September 30, 2023, the increase in cash provided by operating activities is primarily due to increased sales and more efficient conversion of working capital with the easing of supply chain constraints.

The decrease in cash used in investing activities in 2023 relates to increased acquisition payments in the prior year, consisting of $44,596 cash considerations paid in the second quarter of 2022 for the ThinGap, FPH, and Airex acquisitions, offset in part by the cash consideration paid in 2023 relating to remaining payments on prior period acquisitions and closing consideration on the current year acquisition. Cash used in investing activities in the nine months ended September 30, 2023 includes $7,850 for purchases of property and equipment compared to $11,026 during the nine months ended September 30, 2022. Capital expenditures are expected to be between $12,000 and $15,000 for the full year 2023.

26

Table of Contents

The decrease in cash provided by financing activities during the nine months ended September 30, 2023 is primarily due to Amended Revolving Facility borrowings of $47,583 to fund the three acquisitions in the second quarter of 2022. Debt payments of $22,325 were made during the nine months ended September 30, 2023 compared to $6,514 made during the nine months ended September 30, 2022 due primarily to improved operating cash flow generation in the current year. As of September 30, 2023 and 2022, we had $216,052 and $223,132, respectively, of obligations under the Amended Revolving Facility, excluding deferred financing costs.

The Amended Credit Agreement contains certain financial covenants related to minimum interest coverage, total leverage ratio, and non-material subsidiaries assets to consolidated total assets at the end of each quarter. The Amended Credit Agreement also includes other covenants and restrictions, including limits on the amount of additional indebtedness, and restrictions on the ability to merge, consolidate or sell all, or substantially all, of our assets. The Amended Credit Agreement contains financial covenants that require that the Company maintain a minimum interest coverage ratio of at least 3.0 to 1.0 at the end of each fiscal quarter. In addition, the Company’s Leverage Ratio at the end of any fiscal quarter shall not be greater than 4.0 to 1.0 ratio (reduced to 3.5:1.0 for quarters ending on or after December 31, 2023); provided that the Company may elect to temporarily increase the Leverage Ratio by 0.5x during the twelve-month period following a material acquisition under the Amended Credit Agreement (“acquisition leverage increase”), subject to certain exceptions.  The Company was in compliance with all covenants as of September 30, 2023.

As of September 30, 2023, the unused Amended Revolving Facility was $63,948. The amount available to borrow may be limited by our debt and EBITDA levels, which impacts our covenant calculations. The Amended Credit Agreement matures in February 2025.

There were no borrowings under the China Facility during the nine months ended September 30, 2023 and 2022, respectively. The Company closed the China Facility during the three months ended June 30, 2023.

The Company declared dividends of $0.085 and $0.075 per share during the nine months ended September 30, 2023 and 2022, respectively. The Company’s working capital, capital expenditure and dividend requirements are expected to be funded from cash provided by operations and amounts available under the Amended Credit Agreement.

Although there is ongoing uncertainty related to the current geopolitical conflicts, as well as the residual impacts of COVID-19 and variants on our future results, we believe our diverse markets, our strong market position in many of our businesses, and the steps we have taken to strengthen our balance sheet leaves us well-positioned to manage our business through these crises as they continues to unfold. We continually assess our liquidity and cash positions and have assessed the impact of global events on our Company. Based on our analysis, we believe our existing balances of cash, the flexibility of our Amended Credit Agreement and our currently anticipated operating cash flows will be more than sufficient to meet our cash needs arising in the ordinary course of business for the next twelve months.

Item 3. Qualitative and Quantitative Disclosures about Market Risk

Foreign Currency

We have international operations in The Netherlands, Sweden, Germany, China, Portugal, Canada, Czech Republic, Mexico, the United Kingdom, and New Zealand which expose us to foreign currency exchange rate fluctuations due to transactions denominated in Euros, Swedish Krona, Chinese Renminbi, Canadian dollar, Czech Krona, Mexican pesos, British Pound Sterling, and New Zealand dollar, respectively. We continuously evaluate our foreign currency risk, and we take action from time to time in order to best mitigate these risks. A hypothetical 10% change in the value of the U.S. dollar in relation to our most significant foreign currency exposures would have had an impact of approximately $4,666 on our sales for the three months ended September 30, 2023 and $14,682 on our sales for the nine months ended September 30, 2023. This amount is not indicative of the hypothetical net earnings impact due to partially offsetting impacts on cost of sales and operating expenses in those currencies. We estimate that foreign currency exchange rate fluctuations during the three months ended September 30, 2023 increased revenues in comparison to the quarter ended September 30, 2022 by $1,793. For the nine months ended September 30, 2023, we estimate that foreign currency exchange rate fluctuations decreased revenues $1,869 in 2023 compared to 2022.

We translate all assets and liabilities of our foreign operations, where the U.S. dollar is not the functional currency, at the period-end exchange rate and translate sales and expenses at the average exchange rates in effect during the period. The net effect of these translation adjustments is recorded in the condensed consolidated financial statements as comprehensive (loss) income. The translation adjustment were losses of $2,923 and $9,603 for the three months ended September 30, 2023 and 2022, respectively. The translation adjustment were losses of $1,995 and $19,535 for the nine months ended September 30, 2023 and 2022, respectively. Translation adjustments are not adjusted for income taxes as they relate to permanent investments in our foreign subsidiaries. A hypothetical 10% change in the value of the U.S. dollar in relation to our most significant foreign currency net assets would have had an impact of approximately $15,635 on our foreign net assets as of September 30, 2023.

27

Table of Contents

We have contracts to hedge our short-term balance sheet exposure, primarily intercompany, that are denominated in currencies (Euro, Mexican Peso, New Zealand Dollar, Chinese Renminbi, Swedish Krona) other than the subsidiary’s functional currency and are adjusted to current values using period-end exchange rates. The resulting gains or losses are recorded in other expense, net in the consolidated statements of income and comprehensive income (loss). To minimize foreign currency exposure, the Company had foreign currency contracts with notional amounts of $20,851 at September 30, 2023. The foreign currency contracts are recorded in the condensed consolidated balance sheets at fair value and resulting gains or losses are recorded in other expense, net in the condensed consolidated statements of income and comprehensive income (loss). During the three and nine months ended September 30, 2023, we recorded losses of $174 and $270, respectively, on foreign currency contracts which are included in other expense, net and generally offset the gains or losses from the foreign currency adjustments on the intercompany balances that are also included in other expense, net. Net foreign currency transaction gains and losses included in other expense, net amounted to losses of $257 and $54 for the nine months ended September 30, 2023 and 2022, respectively.

Interest Rates

Interest rates on our Amended Credit Agreement are based on Term SOFR plus a margin of 1.00% to 2.25% (1.625% at September 30, 2023), depending on the Company’s ratio of total funded indebtedness to consolidated EBITDA. We use interest rate derivatives to add stability to interest expense and to manage our exposure to interest rate movements. We primarily use interest rate swaps as part of our interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. In February 2017, the Company entered into three interest rate swaps with a combined notional amount of $40,000 that matured in February 2022. In March 2020, the Company entered into two additional interest rate swaps with a combined notional amount of $20,000 that increased to $60,000 in March 2022 and matures in December 2024. In March 2022 the Company entered into an additional interest rate swap with a notional amount of $40,000 that matures in December 2026.

As of September 30, 2023, we had $216,052 outstanding under the Amended Revolving Facility (excluding deferred financing fees), of which $100,000 is currently being hedged. Refer to Note 10, Debt Obligations, of the notes to consolidated financial statements for additional information about our outstanding debt. A hypothetical one percentage point (100 basis points) change in the Base Rate on the $116,052 of unhedged floating rate debt outstanding at September 30, 2023 would have approximately a $300 and $900 impact on our interest expense for the three and nine months ended September 30, 2023.

Item 4. Controls and Procedures

Conclusion regarding the effectiveness of disclosure controls and procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer (principal accounting officer), evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of September 30, 2023. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Based on management’s evaluation of our disclosure controls and procedures as of September 30, 2023, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective.

Changes in internal control over financial reporting

During the quarter ended September 30, 2023, there were no changes in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

28

Table of Contents

PART II.     OTHER INFORMATION

Item 1A. Risk Factors

There have been no material changes to the risk factors disclosed in the Company’s Form 10-K for the year ended December 31, 2022, except to the extent factual information disclosed elsewhere in this Form 10-Q relates to such risk factors. For a full discussion of these risk factors, please refer to “Item 1A. Risk Factors” in the 2022 Annual Report and 10-K.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Recent Sales of Unregistered Securities

On September 22, 2023, the Company entered into a Share Purchase Agreement (the “Purchase Agreement”) with the shareholders (the “Sellers”) of Sierramotion Inc. pursuant to which the Company acquired all of the outstanding shares of Sierramotion Inc. Under the Purchase Agreement, a portion of the purchase price was in the form of equity consisting of 35,380 shares of Company common stock. The securities issued in connection with this transaction were issued by the Company to the Sellers in reliance upon on Section 4(a)(2) of the Securities Act. Each Seller represented that they are an “accredited investor” and will acquire the securities for investment only and not with a view towards, or for resale in connection with, the public sale or distribution thereof.

Issuer Purchases of Equity Securities

    

    

    

Total Number of Shares

    

Maximum Number of Shares

Number of Shares

Average Price Paid

Purchased as Part of Publicly

that May Yet Be Purchased 

Period

Purchased (1)

per Share

Announced Plans or Programs

Under the Plans or Programs

07/01/23 to 07/31/23

 

$

 

 

08/01/23 to 08/31/23

 

 

 

 

09/01/23 to 09/30/23

 

4,562

 

35.83

 

 

Total

 

4,562

$

35.83

 

 

(1) As permitted under the Company’s equity compensation plan, these shares were withheld by the Company to satisfy tax withholding obligations in connection with the vesting of stock. Shares withheld for tax withholding obligations do not affect the total number of shares available for repurchase under any approved common stock repurchase plan. At September 30, 2023, the Company did not have an authorized stock repurchase plan in place.

Item 5. Other Information

None of the Company’s directors or executive officers adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (each as defined I Item 408(a) of Regulation S-K) during the quarter ended September 30, 2023.

Item 6. Exhibits

(a)   

Exhibits

3.1

Amended and Restated Articles of Incorporation of the Company. (Incorporated by reference to Exhibit 3.1 to the Company’s Form 8-K filed June 16, 2010.)

3.2

Articles of Amendment to the Amended and Restated Articles of Incorporation of the Company. (Incorporated by reference to Exhibit 3.1 to the Company’s Form 8-K filed August 23, 2023.)

3.3

By-laws of the Company (Incorporated by reference to Exhibit 3.2 to the Company’s Form 8-K filed August 23, 2023.)

31.1

Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2

Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

29

Table of Contents

32.1

Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2

Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.1 SCH

Inline XBRL Taxonomy Extension Schema Document (filed herewith).

101.2 CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document (filed herewith).

101.3 DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document (filed herewith).

101.4 LAB

Inline XBRL Taxonomy Extension Label Linkbase Document (filed herewith).

101.5 PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document (filed herewith).

104

Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in exhibits 101.) (filed herewith).

30

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

DATE:

November 1, 2023                      

ALLIENT INC.

 

 

By:

/s/ Michael R. Leach

 

 

Michael R. Leach

 

 

Senior Vice President & Chief Financial Officer

31

EX-31.1 2 tmb-20230930xex31d1.htm EX-31.1

EXHIBIT 31.1

CERTIFICATION

I, Richard S. Warzala, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Allient Inc. (the “registrant”);
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s other verifying officer, the auditors and the audit committee of registrant’s Board of Directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: November 1, 2023

/s/ Richard S. Warzala

 

Richard S. Warzala

 

Chief Executive Officer


EX-31.2 3 tmb-20230930xex31d2.htm EX-31.2

EXHIBIT 31.2

CERTIFICATION

I, Michael R. Leach, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Allient Inc. (the “registrant”);
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s other certifying officer, the auditors and the audit committee of registrant’s Board of Directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

ug

Date: November 1, 2023

/s/ Michael R. Leach

 

Michael R. Leach

 

Chief Financial Officer


EX-32.1 4 tmb-20230930xex32d1.htm EX-32.1

EXHIBIT 32.1

Certification of Periodic Financial Reports

Pursuant to 18 U.S.C. Section 1350

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Allient Inc. (the “Company”) certifies to his knowledge that:

(1) The Quarterly Report on Form 10-Q of the Company for the quarterly period ended September 30, 2023 fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934; and
(2) The information contained in that Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 1, 2023

/s/ Richard S. Warzala

 

Richard S. Warzala

 

Chief Executive Officer


EX-32.2 5 tmb-20230930xex32d2.htm EX-32.2

EXHIBIT 32.2

Certification of Periodic Financial Reports

Pursuant to 18 U.S.C. Section 1350

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Allient Inc. (the “Company”) certifies to his knowledge that:

(1) The Quarterly Report on Form 10-Q of the Company for the quarterly period ended September 30, 2023 fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934; and
(2) The information contained in that Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 1, 2023

/s/ Michael R. Leach

 

Michael R. Leach

 

Chief Financial Officer